CA2265984A1 - Enhanced transcutaneous recharging system for battery powered implantable medical device - Google Patents

Enhanced transcutaneous recharging system for battery powered implantable medical device Download PDF

Info

Publication number
CA2265984A1
CA2265984A1 CA002265984A CA2265984A CA2265984A1 CA 2265984 A1 CA2265984 A1 CA 2265984A1 CA 002265984 A CA002265984 A CA 002265984A CA 2265984 A CA2265984 A CA 2265984A CA 2265984 A1 CA2265984 A1 CA 2265984A1
Authority
CA
Canada
Prior art keywords
current
charging
switch
capacitor
battery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002265984A
Other languages
French (fr)
Inventor
Jennifer L. Hay
Xintao Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intermedics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2265984A1 publication Critical patent/CA2265984A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/378Electrical supply
    • A61N1/3787Electrical supply from an external energy source

Abstract

An improved transcutaneous energy transmission device is disclosed for charging rechargeable batteries in an implantable medical device and to minimize peak temperature rises in the implantable device. A current with a sinusoidal waveform is applied to a resonant circuit comprising a primary coil and a capacitor. Current is induced in a secondary coil attached to the implantable medical device. Two solid state switches are used to generate the sinusoidal waveform by alternately switching on and off input voltage to the resonant circuit. The present invention charges the batteries using a charging protocol that either reduces instantaneous charging current or duty cycle of a fixed charging current as the charge level in the battery increases. Peak temperature rises are less while delivering comparable electrical charge to the battery than for prior charging systems. A controller preferably is constructed as a pulse width modulation device with enable and reference voltage features to effectuate variable duty cycle control of the current level applied to the primary coil. An alignment indicator also is provided to insure proper alignment between the energy transmission device and the implantable medical device. The implantable device maximizes transcutaneous energy transmission at different current levels by placing different capacitors into the circuit depending on the magnitude of charging current.
Peak temperature rises are reduced while delivering comparable electrical energy charge to the battery than for prior charging systems.

Description

CA 0226~984 1999-03-17 Description Enhanced Transcutaneous Recharging Svstem for Batterv Powered Implantable Medical Device Technical Field The present invention relates generally to a power source for an implantable medical device.
More particularly, the present invention relates to an external energy transmission device for recharging batteries inside an implantable medical device. Still more particularly, the present invention relates to a charging device for remotely recharging a battery in an implanted medical device. The battery may be of the type disclosed in commonly assigned U.S. P:~tent No. 5,411,537, issued May 2, 1995. entitled "Rechargeable Biomedical Battery Powered Devices With Recharging and Control System Theret'or".
Background Art Currently. battery operable implantable medical devices principally comprise cardiac pacemakers, but also may include heart assist systems. drug infusion and dispensing systems,~
defibrillators, nerve and bone growth stimulators, organ stim~ tors. pain suppressers and implanted sensors, to name a few. The basic cardiac pacemaker generally comprises an electrode, in contact with the heart. that connects by a fle,Yible lead to a pulse generator. The pulse generator includes a microelectronics package. which implements the pacemaker functions, and a power source for supplying operating power to the microelectronics package and other peripheral devices and 'O components. A 'fixed rate" pacem:lker continuously provides timed pulses to the heart. irrespective of proper beating, while a demand inhibited pacPm~ker provides pulses only when the heart fails to deliver a natural pulse. Depending upon the various sensed events, the pacemaker stimlll~tes the right atrium. the right ventricle, or both chambers of the heart in succession. The pacemakers in current use incorporate circuits and antennae to communic~re noninvasively with external programming transceivers. Most pacemakers currently used are of the demand inhibited type, and are programmable.
Early pacem~kers and defibrillators typically were powered by disposable primary zinc-mercuric oxide cells. Although the popularity of this power system persisted for many years, the system suffered from high self-discharge and hydrogen gas evolution. Several mech:lnicm~
contributed to battery failure, most of which were related to cell ch~omi~try. In addition, the open-circuit voltage of each cell was only 1.5V, with several cells connected in series to obtain the voltage required for pacing. Furthermore, because of gas evolution, these prior art pa~em~ker could not be hermetically sealed, and had to be encapsulated in heavy epoxy. In 1970, the average life of the REP LACEMENT

,, ... . , .. . ... , . ~ .......... . . . .....

CA 0226~984 l999-03-l7 W O 98/11942 PCT~US97/16319 pulse generator was only about two years, and about 80 percent of explants were nPcessit,qted by battery failure.
Because of such limitations, many other power generation and power storage devices have been considered as possible alternates. Research and development efforts have focused primarily on rhPmi~.ql batteries, nuclear batteries, and l~ch~lg~able batteries. Additional developmental efforts were directed at dividing the pacing system into two packages, with a power pack located outside the patient's body for tr,qn.~mhting electrical signals through wires to a passive receiver implanted in the body. Cardiac p~emqkPrs based on rechargeable nickel-cq~millm and zinc-mercuric systems also were developed. Examples of such devices are disclosed in U.S. Patent Nos. 3,454,012;
0 3,824,12g; 3,867,950; and 4,014,346. These rechargeable p,q~ernqkPrs incorporated a charging circuit which typically was ene~ d by electromiqgnPtic induction from a device external to the body. The electrom,qgnPti~ induction produced a current in the pacemaker's charging circuit which was converted to a direct current (DC) voltage for charging the battery. Although this system was incorporated in many cardiac pq~PmqkPrs, it was unpopular among patients and physicians because frequent recharging was usually nPcecsqry (somPtimPs on a weekly basis), and because the nickel-cfl~lminm system suffered from memory effects which reduced the battery capacity exponentially after each recharge. In ,q,~l~lition, the specific energy density of both types of rechargeable batteries was poor, cell voltage was low, the state-of-charge condition was difficult to ascertain, and hydrogen gas liberated during overcharge was not properly scavenged either through a recombination reaction, or hydrogen getters.
Charging nickel-cq 1millm cells and zinc-mercuric oxide cells is problematic. Cells of these types have a relatively flat voltage versus time curve during the charging process. The flat slope of the voltage time curve during charging provides little resolution to ascertain accurately the in.~t,qnt,qnPous percentage of full charge. Accordingly, these cells (especially nickel-ca~mi-lm), provide a poor inf1icqtion of the charge level. Additionally, overcharged nickel-c~-lmillm cells liberate oxygen exothermically at the nickel which migrates to the cq~lminm electrode and recombines to form ca-lmil~m hydroxide. In some situations, particularly during an overcharge condition, the rate of oxygen evolution is higher than the rate of oxygen r~coll~billdlion. This may lead to an excessive internal pressure, forcing the cell to vent the excess gas. The overcharge reaction also heats the cell which in turn lowers cell voltage. Therefore, charging is t~ r.d when the battery voltage begins to decrease, thus in-lir,qting the beginning of an overcharge condition.
Other techniques for controlling the charging operation have been employed. For example, U.S. Patent No. 3,775,661 teaches that the pres~ule build-up internally can be sensed by a diaphragm that is external to the battery. As the pressure within the cell casing increases, the CA 0226~984 1999-03-17 diaphragm is flexed to actuate an associated mPrh:lni~l switch located in the battery charging circuit.
The closure of the switch dee.lelgi~es the charger when the battery internal pressure in~iir~Ps a fully charged state.
In somewhat similar fashion, U.S. Patent No. 4,275,739 employs a diaphragm internal to the cell. Deflection of the diaphragm during an episode of incre~sing internal pressure indicates the cell has reached a full charge. Other examples of systems which control charge operation are U.S.
Patent Nos. 3,824,129; 3,888,260; 3,942,535; and 4,082,097.
Today, systems employing nickel-c~millm cells control battery charging use a variety of different charging techniques. Common parameters for ascertaining the end-of-charge condition include maximum voltage, maximum time, maximum temperature, a reduc~ion in cell voltage with respect to time, (dV/dt,) change in temperature ~T, and increase in temperature with respect to time (dT/dt). Details of these end-of-charge indicators can be found in EDN, Mav 13, 1993.
Both zinc-mercuric o,Yide and nickel-~a~millm cells suffer from additional problems such as memory effect and high self-discharge. Fast recharge often is implemented by charging the battery to some preselected voltage with a relatively high current followed by a smaller trickle charge. It is known that nickel-cadmium batteries that are fast charged cannot be charged to 100 percent of rated cell capacity. This loss of capacity is called the memory effect. Each time the battery is discharged at some low current rate, and then recharged at a higher current rate, a loss in capacity results. The capacity loss of each recharge cycle accllmlll~es. Cells affected by the memory etfect then have to be fully discharged and "reconditioned" before full capacity can be recovered. Because of this loss of capacity and high self-discharge, p~rPm~k~rs with cells that suffered a memory effect had to be frequently recharged, sometimes on a weekly basis. In theory, rechargeable battery powered p~-~P~ kers were designed for a 10 year usable life. Battery chemistry problems. however, reduced the device's usable life to two or three years, the same lifetime as that of the earlier devices that employed disposable primary cells. As a result of the inherent limitations in zinc-mercuric oYide and nickel-c:lllmillm battery cells, the assignee of the present invention has suggested the use of lithium batteries. See U.S. Patent No. 5,411,53~, issued May 2, 1995.

An additional problem arises with respect to recharging an implanted device's rechargeable battery. Due to the health risks and costs associated with surgical intervention, it is highly undesirable to perform surgery to access the implanted device and recharge the batteries. Some noninvasive methods for l~cha~ g implanted batteries are disclosed in the prior art. Cert~in patents disclose a technique for delivering electrical energy through the skin between a transcutaneous energy transfer device and an implanted medical device. For example, U.S. Patent No. 5,350,413 REPLACEMENT

CA 0226~984 1999-03-17 discloses a tr:lngrut~nPous energy transfer device Co~ isillg an external primary coil located on or near the skin, and a secondary coil for illl~,ld..lalion under the skin. The primary and secon-l~ry coils form a transformer so that electrical current in the primary induces current in the secondary coil.
An approximation to a half-wave sinusoidal voltage is developed across the primary winding by the action of a field effect lla~ lOl (FET) ~wil~;llillg a direct current (DC) voltage source across a tuning capacitor. Because of the construction of the energy llA~ c~ion device, high frequency harmonic c~Jlllpolle-lL~ are present in the waveform. These high frequency cu~ one~ induce eddy currents in the housing of the implanted device. The t~ eral~lre of the housing hlCI eases in response to the eddy currents, and can also increase in response to the elevated l~ alui~ of the battery during charging. A rise in l~lllpel~lule of the outer surface of the housing may be detrimental to operation of the medical device and harmful to ~Illluu~ lg body tissue. Industry standards suggest maximum allowable temperature rises. l imi~ing a temperature rise (i.e., peak temperature) is desirable to minimi7P the harmful effects on surrounding body tissues. Prior art systems, however, for the most part have not examined methods for reducing temperatures rises.
The prior art rechalgi.. g devices suffered seveMl drawbacks. First, many prior art systems either did not have a feature for properly aligning the external device on the patient's body over the irnplanted device or had such a feature but required additional circuitry (and therefore increased cost, volume, and power drain) and lacked sufficient accuracy. In addition, some prior art devices have an :~lignml~n~ mPrh~nicm which requires the recharging device to be turned off while ~lignmPnt is measured. Also, the charging distance between the external and internal devices was limited requiring the implanted medical device to be located relatively close to the skin. Further, some systems inrlnded on ill.l)lalllable device COl~i~Li~g of two separately housed parts, an electronics unit and a receiving coil, which ill~;reased the difficulty and risk associated with surgical implantation as well as reducing the quality of the herrnetic seal.
It would be desirable to provide a battery charging system that overcomes these and other problems associated with rechargeable implantable devices. In particular, it would be desirable to construct a battery charging device which can efficiently charge a battery in an implanted medical device at a relatively high power transfer rate while reducing the peak Lt~ Jel~lUle generated by the device. Similarly, it would be desirable to develop an ~lignmPnt mech~ni.~m that is located in the recharging device, which requires no extra components in the irnplanted device besides those components needed for charging. It would further be advantageous to develop an energy tr:lncmi~gion system that "~ ;"~ s the size of the receiving coil and perrnits the coil to be located inside the housing of the implantable device. Despite the apparent advantages of such a system, to date no such system has been developed.

CA 0226~984 1999-03-17 WO 98/11942 PCT/US97tl6319 Disclosure of the Inventi- n The present invention overcomes the shortcomings and deficiencies of the prior art by providing a trAnccutAnPous energy llA~ sion system with two external solid state switches that produce a sllhs~ntiqlly si,l.lsoilal power waveform. The solid state switches connect a regulated DC
voltage across an inductor and capacitor resonant circuit. The inductor forms a primary coil of a l,d~ro"~ in which current is induced in a secondary coil attached to an implanted medical device.
The implanted medical device receives the induced current for charging leclla.~able batteries. Two different charging protocols are implPmPntPd to minimi7e the peak t~lllpelaLule produced on the outer surface of the housing of the implanted device housing or can.
Using a first charging protocol, an initial relatively high charging current is generated by an external charging device, followed by a lower charging current. The present invention includes a primary current control circuit that provides control signals to an inverter. Based upon the status of the control signals, the invention produces charging current at either a high or low level to provide efficient charging without an excessive t~ lalule rise in the implanted device.
Charging efficiency is maximized through the use of two dirrere"L resonant circuit configurations in the implanted medical device. An antom~fir ~lviLcl~ing mrrhAnicm is used to switch between the two resonant circuit configurations based on the m~gnitllde of charging current. In one configuration, a capacitor connected in parallel across the secondary coil is used for relatively low levels of charging current, whereas a series connected capacitor is used for higher charging current levels. A current sensor provides an input to a switch drive that activates switches to connect one or the other of the capacitors to the charging circuit based upon the m:lEnitn(l~P. of the charging current.
In a second charging protocol, the trAnccutAnPous energy Ll~ inn device produces a relatively high charging current to the battery, but is periodically illl~llu,uled by periods without any 25 - ~,hdl~ g current. The resulting duty cycle of the charging current is adjustable to allow for different levels of average charging current to the battery. An effective current step is thus generated by reducing the duty cycle of the charging current from an initial high level to a lower level. The initial charging duty cycle preferably is 100% (constant DC current). Because only one relatively high charging current is produced, albeit illlell~lpted by periods of no current, only the series connected capacitor is used and no automatic switching mPc.h:.ni.cm and parallel capacitor are nPcesc~ry ~
The coils of the external energy Lldl~ ion device and the implanted medical device must be properly aligned for efficient energy Llall~lllission. Accordingly, an Alignm~nt circuit and indicator are provided to indicate whether the coils are properly aligned The AlignmPnt circuit . .

CA 0226~984 1999-03-17 continuously senses current in the primary coil to determine whether the angular and lateral ~lignmPnt is optimal by sensing a peak DC current. A visual and/or audible signal is provided only when the charging coil is sl-hst~nti~lly in ~lignment with the receiving coil in the implanted device thereby in~lic~fing proper ~lignment Brief Descr~tion of the Dl~wi.~.~
Other objects and advantages of the invention will become apparent upon reading the following detailed description and upon reference to the accompanying drawings in which:
Figure 1 is a drawing showing the external l~ ;u(~ ous energy tr~n~mi~ion device and implantable medical device of the present invention positioned to charge the batteries in the implantable device;
Figure 2 is a sçhem~tir block diagram of the plerelled circuit i.,.~l; "P~ ion of the present invention;
Figure 3 is a ~l~phical illustration depicting the telll~Je-dtule rise which occurs during battery charging for constant current prior art chargers relative to the charging protocols of the present invention;
Figure 4A shows a charging protocol for a typical prior art charging system;
Figure 4B shows a ~lefelled charging protocol for use with the invention of Figure 2;
Figure 4C shows an alternative charging protocol for use with the invention of Figure 2;
Figure 5 is a s~hem~tic block diagram providing additional details regarding the inverter, PWM controller, and ~lignmPnt indicator of the ~ n~ nPous energy transmission device shown in Figure 2;
Figure 6 is a timing diagram depicting the voltage at switches SW1 and SW2 in Figure 5;
Figure 7 is timing diagram depicting the use of a voltage reference to the PWM controller of Figure 5 to change the m~gnitllde of the primary coil current;
Figure 8 is an electrical srh~om~tic diagram showing additional details of the inverter circuit of Figure 5;
Figure 9 is an electrical srhPm~tie diagram of an amplifier constructed in accordance with a preferred embodiment of Figure 5;
Figure 10 is an electrical sch~m~tic diagram showing the preferred peak detector circuitry of Figure 5;
Figure 11 is an electrical s. h~ ir diagram depicting the ~;lirrelellce amplifier and associated circuitry of Figure 5;

CA 0226~984 1999-03-17 Figure 12 is an electrical schPm~tir diagram of the comparator and LEn circuit of Figure 5;
Figure 13 shows a cu-l-pa~isoll of charging efficiency versus current m~gnitl--le for different tuning capacitor configurations; and Figure 14 is an electrical sCllpm~tic of for the implantable device in charging circuitry accordance with the prerel.~d embodiment.
While the present invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that the dl~willgs and detailed description thereof are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the present invention as defined by the appended claims Best Mode for Carryin~ Out the Invention Referring now to Figure 1, the l~ c~ nPous recharging system of the present invention includes a L~ Pous energy tr~ ;on (TET) device 50 and an impl~ntPd medical device 14.
In Figure 1, the medical device 14 is shown implanted beneath the skin in the chest or pectoral region of the patient, as might be the case with a defibrillator device, with external TET device 50 positioned on, or near, the surface of the skin and placed proximally to the implanted device 14.
One skilled in the art will understand, however, that the energy tran~mi.c.~inn device 50 may be used to charge any implanted medical device, wherever located. In accordance with the preferred embodiment, the implanted medical device 14 is housed in a housing or "can" made of titanium or stainless steel. Although the energy tr~n~mi~.~ion device 50 is shown with a generally rectangular configuration it should be understood that the energy tr~n~mi~ion device may take any desired shape. Power to the TET device 50 is provided via cord 3 from an external power source such as a 120 VAC outlet on batteries (Figure 2). An indicator 131 illnmin~tPc when TET device 50 is correctly aligned with the implanted device 14 for maximum charging efficiency.
Referring now to Figure 2, TET device 50 of the tr~n~c lt~nP.ous recha~ ,g system generally Colll~ CS a AC/DC converter 5 and an inverter 20 connecting via conductors 6. An alignment ~ indicator 40 also cormects to the inverter 20 to receive signals from inverter 20 when the TET device 50 is properly aligned with respect to the implanted medical device 14 for m~imnm efficiency. A
pulse width modulation (PWM) controller 200 controls the output power level of inverter 20 (and thus the charging current). The PWM controller 200 can also periodically hlLe~ L the inverter's charging current, thus producing a duty-cycled charging current. The TET device 50 COlll~uOIIelll~
preferably are housed in a single enclosure 51. In the preferred embodiment, an alternating current CA 0226~984 1999-03-17 is converted substantially to a DC voltage by AC/DC converter 5 which also regulates the DC
voltage at a level appropriate for tr~n~cu~:ln~ous energy ll,~n~",i.c~ion. AC/DC converter 5 also provides operational power to PWM controller 200 over conductor 201~ One of ordinary skill in the art will recognize that a mllltinlfle of Icnown circuit implem~ont~tions are possible for AC/DC
converter 5, and thus the present inveMion should not be limited to any particular embodiment for AC/DC converter 5.
The regulated DC voltage output signal of the AC/DC converter 5 is tr~n~mi~ted to the inverter 20, which converts the regulated DC voltage output to a sinusoidal current that flows through primary coil 9. Electrical current in primary coil 9 electromagnetically induces a corresponding current in a secondary coil 10 which preferably is located in the implanted medical device 14. Alternatively, secondary coil 10 may be external to housing 15 of the implanted device 14, but electrically coupled to the implantable device 14. In either case, the electrical energy of primary coil 9 couples tr~n~cut:-n~ously between primary and secondary coils through the patient's skin 100.
Referring still to Figure 2, the implanted device 14 preferably includes a rectifier 12, battery 13 and a resonant circuit comprising secondary coil 10, parallel capacitor 410, and series capacitor 420. The resonant circuit in the implanted device 14 preferably is tuned to the frequency of the AC
current in the primary coil 9 Capacitors 410 and 420 are both removable from the circuit by switches 411 and 421. respectively. A switch drive logic 300 controls the state (open or closed) of switches 411 and 421 via lines 301 and 302 depending on the amount of curreM through battery 13, as indicated by current sensor 270.
The rectifier 12 converts the sinusoidal voltage received by the secondary coil 10 to a DC
voltage for charging the battery 13. The rechargeable battery 13 preferably comprises any of a number of different lithium chemistries, as disclosed in detail in commomy assigned U. S . Patent No.
5,411,537. One of ordinary sKill in the art, however, will recognize that the presen~ invention may also be used to recharge other types of batteries, as desired.

When an alternating magnetic flux passes through a metal plate, eddy current is generated in the metal plate. The m~gni~lde of eddy current is a function of frequency and m:lgnitl-dP of the m~gn~ti~ flux. Eddy currents cause temperature increases. For implantable devices such as defibrillators, eddy currents are induced on the can and metal casings of components internal to the implantable device. A high charging current, therefore, creates large ~ ,lp.,.dture rises. The present invention advantageously manages the level of charging current over time so as to minimi7e peak REPll~CEMENT

.

CA 0226~984 1999-03-17 WO 98/11942 PCT/US97tl6319 invention advantageously manages the level of charging current over time so as to ~ i7~ peak le~ elalul~ rises without reducing the amount of charging energy delivered to the implantable device.
For typical prior art charging systems, which often implement constant current charging S protocols, the temperature rise ~ les~ d by curve I in Figure 3 is exemplary. The present invention is capable of delivering the same amount of energy to the battery in the same amount of time as prior systems, but can do so in such a manner that the peak L~ lalule of the battery is less than it would be for prior systems, Curve II exemplifies the l~ e~aLul~ rise response of the present invention. Significantly, the peak temperature produced by the present invention is less than the peak temperature of the prior art charging system represented by curve I, as reflected at point P.
Prior art recharging systems often charge the battery at a constant current as exemplified in Figure 4A. As shown in Figure 4A, a prior art constant current IPA is delivered to the battery for the entire charging period. To deliver the same amount of energy to the battery in the same period of time, the recharging system of the present invention preferably initially delivers to the battery a charging current I, (which is higher than IPA) for a first predetermined period of time, followed by a lower current I2, which is lower than IPA for the rem~inder of the charge cycle as shown in Figure 4B. The energy delivered and time required using the recharging system of the present invention embodied in the preferred protocols of Figures 4B and 4C are s~-bst~nti~lly the same as the energy delivery and time requirement for the prior art charging protocol of Figure 4A. However, the peak temperature rise of the implantable device can 15 is less using the protocol of Figure 4B, referred to in this description as the "current step" protocol.
An alternative method for achieving the same result is shown in Figure 4C. Using this protocol, a charging current I3, which is higher than IPA~ is delivered to the battery with hllellllillenl periods with no charging current. Because of the periodic intervals without current, the effective charging current per unit time is substantially less than the peak current I3. Moreover, the average current delivered to the battery is a direct function of I3 and the duty cycle of the charge current waveform. The average current, therefore, is higher during the charging period in which a higher duty cycle is used as in~ t~d in interval H in Figure 4C. As the duty cycle is reduced during internal L, the result is a lower average charging current. The charging protocol of Figure 4C is hele.llarler referred to as the "duty cycle" charging protocol. The resulting effect of this duty cycle charging protocol is a step-down in average charging current.
Consi~lelll with the pl~rel~cd embo-lim~nt a duty cycle of 100% may be implent~nt~d during the H interval of the charging protocol of Figure 4C. In other words, the initial high charging current phase of the protocol of Figures 4C may be identical to that of Figure 4B, but where the CA 0226~984 1999-03-17 protocol of Figure 4B reduces the current m~gnit~ P to 12, the protocol of Figure 4C m:~int lin.C the same high current m~gni~lde while duty cycling the current waveform to achieve a lower average charging current.
Figures 5-8 show ~l~r~llcd h~ ions of the circuitry employed to achieve the charging protocols shown in Figures 4B and 4C. Referring initially to Figure 5, the PWM controller 200, inverter 20, and ~lignmPnt indicator 40 of TET 50 are shown in more detail. In accordance with the preferred embodiment, the inverter 20 includes a pair of switches 21, 22, a pair of capacitors 26, 29, and a tuning capacitor 25. The PWM controller 200 preferably includes a pulse controller 231, a pulse generator 232, an RC oscillator 233, resistor 233R, and capacitor 233C. One of ordinary skill in the art will recognize other circuit impl.omPn~:ltions are possible for PWM
controller 200. The PWM controller 200 preferably includes functions such as dual output capabilities and high source and sink current.
High frequency h~rmc ni~ content in the current con~l~lrtPd through primary coil 9 will induce eddy currents in the housing or can 15 of the implantable medical device 14 causing a detrimental increase in can te~ dt~re. In addition to the benefits provided by employing the preferred charging protocols of Figures 4B and 4C, the present invention advantageously minimizes the increase in can temperature ~\T by geneldli-lg a charging current signal having a sllhst~nli~lly full sinusoidal waveform with little harmonic content. This sinusoidal charging current signal is transcutaneously I~A~ d to the implanted medical device 14 to charge the battery 13. To generate the desired ~ t~ical sinusoidal waveform, the inverter 20 includes two switches, 21 and 22 (SWl and SW2, respectively). Preferably these switches 21, 22 are solid state devices and, as shown in Figure 8, may be irnplPmPnt~ d with metal oxide field effect transistors (MOSFET's) 21 and 22. As shown in Figures 5 and 6, the output of pulse ~ lol 232 turns switches 21 and 22 on and off alternately such that only one switch is "on" (i.e., con~ cting electricity) at any given time. As shown in Figure 6, a short time period D (for example, 2 mieloseconds) is provided after one switch turns off and before the other switch turns on. This "dead time" between activation of switches 21, 22 insures that the switches are not on simlllt~n~ously which may cause a short circuit condition between the voltage input terminal V", and ground. The dead time between swit~;lling off one switch and turning on the other preferably is modified to control the charging current applied to the batteries, COnSIDI~III with the current step protocol of Figure 4B, and as described more fully below.
Increasing the time when both switches 21, 22 are off results in a decrease in the power supplied to the primary charging coil 9.
Switches 21 and 22 preferably are turned on for the same amount of time each cycle to produce a symmetrical voltage waveform across junctions 30 and 31. Capacitors 26 and 29, which CA 0226~984 1999-03-17 preferably have i~lPnric~l values, form a voltage divider network. Tuning capacitor 25 connects between the common connection point for capacitors 26 and 29 (junction 30) and terminal 32 of l~dl~rulmer 9. It should be noted that this duty cycle is not the same duty cycle described in Figure 4C. The implempn~ on of the duty cycle protocol of Figure 4C is described below.In order to ~ the eddy current induced in the housing or can 15 of implantable device 14, the operational (or carrier) frequency of the PWM controller 200 preferably is set at 5 KHz, but it may be set to operate within a range of 1 KHz and 40 KHz. Tuning capacitor 25 is selected to generate the desired current amplitude with the primary coil 9 leakage inrlllr.t~nre so that a sinusoidal all~ d~hlg current waveform flows through the primary coil 9 with little high frequency harmonics.
Through proper selectiûn of the value of capacitor 25, the natural resonant frequency of the resunalll circuit formed by primary coil 9 and capacitor 25 can be controlled to be slightly less than the operational frequency in order to achieve the zero-voltage turn-on of both switches 21 and 22.
In general, the inverter 20 produces a purely sinusoidal transfer current waveform between coils 9 and 10 using a resonant circuit comprising the leakage in~ ct~nre of primary coil 9 and tuning capacitor 25. Resonance is continuously m~int~inP.d by alternately activating switches 21 and 22. The present invention can provide a wide range of charging current from 0 to 1 amperes and charging voltage from 0 to 20 V. The distance between coil 9 and coil 10 preferably is less than 2.5 inches. Although a purely sinusoidal current waveform is preferred to reduce eddy currents (and thus temperature elevation) which in part are created by higher frequency harmonics, the present invention further reduces 1e~ el~lu.~ rises by using the charging protocols of Figures 4B and 4C
as described below.
Referring now to Figures 5 and 7, PWM controller 200 controls the time when switches 21, 22 (SW1 and SW2, respectively) turn on, as well as the time period during which the switches are activated. Resistor 233R and capacitor 233C connect between RC oscillator 233 and ground. RC
oscillator 233 provides a periodic signal. As one of ordinary skill in the art will recognize, the voltage across capacitor 233C, as inrlir~ted by Vc in Figure 5, is substantially a saw-tooth voltage waveform as shown in sub-part (a) of Figure 7. Superimposed on the saw-tooth Vc waveform is an exemplary current control signal provided by the pulse controller 231. As shown in Figure 5, the current control signal is ~ lPd to the VREF input terminal of pulse gene.~lol 232 via conductor 250. Figure 7 demonstrates how the current control signal on line 250 can be used to achieve different levels of charging current and the curreM step protocol of Figure 4B. The GATE signals (GATE1 and GATE2) from the pulse genelaLol 232 are coupled to the gate inputs G of switches 21, 22. These GATE signals dictate when each of the switches 21, 22 are turned on. Alternating cycles of the sawtooth Vc waveform of Figure 7 are used to generate the GATE signals. The first Vc cycle CA 0226~984 1999-03-17 shown in Figure 7 produces the first GATE1 pulse in sub-part (b) of Figure 7. The second Vc cycle produces the first GATE2 pulse in sub-part (c) of Figure 7. The third Vc cycle produces the second GATE1 pulse, and so on. Each pulse is generated when the Vc voltage rises above the voltage of the current control signal (VREF). The width of each GATE pulse is dictated by the point when Vc rises above VREF and the point where Vc drops below VREF, exemplified in Figure 7 as the pulse PW1. Accordingly, by hlcleasillg the level of the current control voltage on the VREF terminal of pulse generator 232, the width of the GATE pulses are reduced as shown by pulse PW2 in Figure 7. As described above, increasing the time when both switches 21, 22 are "off" reduces the m~gnitll(le of primary coil current, and thus charging current, as intlic~t~d in sub-part (d) of Figure 7 at D1. Thus, the current control signal on line 250 is used by the pulse generator 232 as a reference value to vary the duty cycle of switches 21, 22 and thus control the charging current.
The pulse generator 232 preferably includes an enable input terrninal (EN) which controls the status of PWM controller 200. When an enable signal is provided to the enable input via line 255, the controller is enabled. Conversely, if a disable signal appears on line 255, controller 200 is disabled. More specifically, the pulse generator 232 is enabled and disabled. According to the preferred embodiment, the enable/disable signal on line 255 is used to define a duty cycle for the current delivered to primary coil 9, according to the charging protocol of Figure 4C.
The enable signal preferably is generated by the pulse controller 231 and ~ n~ Pd via line 255 to the enable (EN) input terminal of the pulse generator 232 to turn the pulse geneldtor on and off. Thus, for example, a logic "0" on the enable input line 255 may turn the PWM controller on, while a logic " 1 " turns it off. Once the pulse generator 232 is turned off through the enable signal, no current flows through the primary coil 9 and thus, the battery is not charged during the period when controller 23 is disabled. The pulse controller 231 preferably produces an enable signal sirnilar to the duty cycle waveform of Figure 4C. As ~ cllc~ed above, the resulting charging current is determined by the amplitude of the charging current when the pulse generator 232 is enabled (on) and the duty cycle of the enable input signal as one of ordinary skill in the art would understand.
The amplitude of the charging current when the PWM controller 23 is on can be preset through a specified current control voltage (VREF) on line 250. Thus, the PWM controller 200 can direct the inverter 20 to produce a step down average charging current by geneldlillg an enable signal with a variable duty cycle, thereby interrupting the gate signals to switches SW1, SW2. The average charging current is directly related to the duty cycle of the enable signal. ~t should be noted that for the step down current protocol of Figure 4B, the PWM controller's enable input is contimloll~ly asserted to constantly m~int~in the pulse generator 232 in the on condition.

CA 0226~984 1999-03-17 WO 98/11942 PCT/US97tl6319 Referring now to Figures 5 and 8, switches 21 and 22 preferably are impl.om~nt.od with MOSFET devices. The pulse generator 232 (Figure 5) COllllfCI~ to the gate G and source S terminals of MOSFET switch 21 through conductors 98 and 97 (Figures 5 and 8). The source terrninal S of MOSFET 21 and the drain terminal D of MOSFET 22 connect to terminal 31 of primary coil 9. The S drain terrninal D of MOSFET 21 c~-nn~ctC to capacitor 26 and also receives the input regulated DC
voltage Vjn on conductor 8 from AC/DC converter 5 (Figure 2). The gate terminal G of MOSFET
22 connects to the GATE2 terminal of controller 23 via conductor 27. The source terminal S of MOSFET 22 provides a path for current from the primary coil 9 to ground through the current sensing resistor 42 of the :~lignmPnt indicator 40. When switch 21 (SW1) turns on, a current path is completed from Vjn, through switch 21, node 31, coil 9, capacitor 25, node 30, and capacitor 29 to ground. When switch 22 (SW2) turns on, a current path is completed from Vjn, through capacitor 26, node 30, capacitor 25, coil 9, node 31, switch 22, and resistor 42 to ground.
Referring now to Figure 5, an additional advantageous feature of the present invention is an indicator for providing a visual indication of when the TET device 50 is properly positioned with respect to implanted device 14 for m~xim~1m charging efficiency. When switch 22 is turned on by controller 23, current flows from primary coil 9 through switch 22 and to resistor 42 in ~lignm~nt indicator 40. Due to the symrnetric AC current on the prirnary coil 9, the current through the switch 22 comprises half of the coil current during one-half the time of each cycle of the AC waveform.
Thus, only half of the primary coil current is received by resistor 42. In the preferred embodiment, the DC component of the voltage across the resistor 42 is used as an indication of DC input current from the voltage source Vjn.
Alignment indicator 40 provides a light emitting diode (LED) in LED circuit 48 or other output device to indicate proper positioning of the TET device 50 with respect to implanted device 14. The TET system can be tuned so that the amplitude of the AC current through the primary coil 9 decreases when the primary coil 9 is not properly aligned with secondary coil 10. The input DC
current, therefore, depends on the power draw of the load on the secondary coil and the proximity and orientation of the primary coil 9 to the secondary or receiving coil 10. Therefore, a mca~ulcl.lent of the m~gnitu(le of the input current preferably is used in the present invention to d~ ,lli--e if the TET device 50 is positioned properly for m~ximllm energy ~ .";.c.~ion efficiency.
The following discussion details the construction and operation of the ~lignm~nt indicator 40 which uses the correlation between the input current and ~lignmPnt to provide an output signal which in(li(~.~t~s when the energy ~ ion device 50 is sufficiently aligned with the receiving coil 10 of the implanted device 14.

CA 0226~9X4 1999-03-17 Referring to Figure 5, the re~ict~n~e value of resistor 42 preferably is small to minimi7~ the loading effect on the inverter 20 that would otherwise result. In the preferred embodiment, resistor 42 is selected as approximately 0.5 ohms. It will be understood that the purpose of resistor 42 is to sense current in the primary coil 9 and provide an output signal indicative of the current amplitude and phase shift. Accordingly, although a resistor is preferable, any current sensing device can be used in place of resistor 42.
Referring still to Figure 5, the ~lignment indicator 40 preferably includes a low-pass amplifier 43, a peak detector 45 to detect the peak DC current amplitude through switch 22, a differential amplifier 46 to amplify the difference between the peak current amplitude and the amplitude of the output current signal from low-pass amplifier 43 on line 108, a comparator 47 to compare the amplified difference with ground voltage, and an LED or other output circuit 48. In the preferred embodiment, the LED circuit 48 (or other output device) only provides.an output signal intli~ ing ~lignm~ont if the present sensed current amplitude is within a predetermined range of the peak value.
Current flow through resistor 42 from switch 22 generates a voltage Vs across resistor 42 which is amplified and filtered by low-pass amplifier 43 to effectively obtain the DC component of the waveform through resistor 42, and to filter out the AC portion of the waveform. The peak detector 45 senses the peak amplitude value of the output signal on conductor 108, which connects to the output terminal of the low-pass amplifier 43. The peak detector 45 stores the peak value, unless a higher amplitude is snhsPq-lPntly sensed. If a higher value is subsequently sensed, the peak detector 45 replaces the stored peak value with the new peak value. The output signal of the peak detector 45 on conductor 116 c~ pollds to the peak positive voltage sensed by the peak detector 45. This peak voltage (which is scaled to provide a threshold value that is somewhat less than the peak value), is provided as an input to the dirre-enlial amplifier 46. The other input to the differential amplifier colll~lise5 the current sensed output of the low-pass amplifier 43 (conductor 108). The dir~.~.-lial amplifier 46 amplifies the dirrere.lce between the scaled peak value, and the present sensed value, and provides an output signal to co---l)al~ol 47. Co--lpal~lul 47 compares the difference with ground voltage, and turns on the LED circuit 48 when the current sensed value is greater than the scaled peak value. This condition will occur when the TET device 50 is positioned properly over the implanted device. In order to capture the O~ti~ llll Iocation, the primary coil 9 has to pass the optimal location at least once to let the peak detector 45 record the peak DC current value. Thereafter, the LED circuit 48 will not be turned on unless the primary coil 9 stays at the optimum location and orientation. If the lateral pl~ç~m~nr of the TET device is mi.c~lignPd with respect to the receiving coil, or if the TET device 50 is positioned at a nonoptimal angle with respect CA 0226~984 1999-03-17 to the implanted device for peak lla~ ion ~rriciency, the scaled peak value will be greater than the present output voltage at the output terminals of filter 44, and the comparator 47 will produce an output signal de-activating the LED circuit 48.
One of ordinary skill in the art will recognize that a plurality of circuit implp-mpnr~ions are possible for the low-pass amplifier 43, peak detector 45, dirrelelllial amplifier 46, comparator 47, and LED circuit 48 of ~lignmP.nt indicator 40. In addition, the functions of two or more of these co~ on~ may be pelrolllltd by a single device. The circuit Srl,r~ 'ir,s of Figures 9-13 are shown as the preferred embodiment of the alignmPnt indicator of the present invention.As noted above, the voltage waveform across resistor 42 includes both AC and DC
0 CUIIIIJOnel1~. In the preferred embodiment, the AC component is filtered to permit ex:~min~ion of the DC component. Referring now to Figures 5 and 9, low-pass amplifier 43 is configured as an inverting amplifier, with an operational amplifier 103, an input resistor 102, a feedback resistor 105, a feedback capacitor 106, and an output resistor 107. The negative ratio of the resistance of feedback resistor 105 to the 1~ t,~l~re of resistor 102 (lrlf~ Ps the DC voltage gain of the amplifier 43. Preferably, the gain is set at 100. Therefore, the re.Ci.~t~nre of resistor 105 should be one hundred times greater than that of resistor 102. R~.si.ct~nce values of 44.9 Kohms for resistor 105 and 449 ohms for resistor 102 are pler.,.led, but numerous other values are possible. Capacitor 106, together with resistor 102, provide low-pass filter capabilities to amplifier 43. A resistor 104 connects the non-inverting input terminal of operational amplifier 103 to ground. The output terminal of operational amplifier 103 connects to feedback resistor 105, capacitor 106, and output resistor 107. The output of amplifier 43 (which preferably in-lir:l~Ps a negative voltage value) is provided on conductor 108 to peak detector 45.
Referring now to Figures 5 and 10, the preferred construction and operation of the peak detector 45 will now be described. ln the preferred embodiment, peak detector 45 colllylises an operational amplifier 114, peak storage capacitor 120, and voltage follower 46. The low-pass amplifier 43 connects through conductor 108 to the non-inverting input terminal of operational amplifier 114. The output terminal of operational amplifier 114 connects to the cathode of diode 117, the anode of which co~ e-;L~ to the cathode of diode 119. Current from operational amplifier 114 (with a negative amplitude) flows through diodes 117 and 119, charging storage capacitor 120 to a voltage indicative of the peak value at the non-inverting input of operational amplifier 114.
Diode 115 prevents operational amplifier 114 from saturating in the absence of peak values, and resistor 216 provides a path through which the current from diode 115 can flow. Switch 122 resets the peak detector output signal to 0 V upon closure of that switch.

CA 0226~984 1999-03-17 WO 98tll942 PCT/US97/16319 When a new peak arrives at the non-inverting input of operational amplifier 114, the output of op amp 114 swings in the negative direction, turning diode 115 off (preventing current flow through resistor 216) and turning diodes 117 and 119 on, pc~ lg capacitor 120 to charge. As the input voltage on conductor 108 drops, the output of operational amplifier 114 swings in the positive direction, turning off diode 117 and diode 119. As a result, c~citcr 120 m~int~in.c its peak voltage charge, with diode 119 and resistor 118 limiting the leakage of capacitor 120. As the output voltage continues in the positive direction, diode 115 turns on to prevent saturation of the op amp 114.
The voltage follower buffer 121 not only provides a high input impedance to ,,,il,i..,i,~.
loading on other stages of the circuitry, but also scales down the peak detected voltage through the use of a manually adjustable potentiometer 118. Potentiometer 118 connects between the output of operational amplifier 121 and ground to provide an adjustable voltage divider in which conductor 116 carries the scaled down peak voltage to an input of differential amplifier 46. The output of operational amplifier 121 is fed back to the inverting input of amplifier 121 and is provided via conductor 115 to peak detector 45.
Referring now to Figure 11, the dirr~lellLial amplifier 46 preferably cul~ ises an operational amplifier 123, a feedback resistor 122b, and input resistors 120, 122a. The output signal from peak detector 45 couples to the inverting input terminal of operational amplifier 123 through resistor 122a.
The output signal from the low-pass amplifier 43 couples through resistor 120 to the non-inverting input terminal of operational amplifier 123. Operational amplifier 123 amplifies the difference between the scaled peak value on conductor 116, and the present sensed value on conductor 108, and provides the amplified difference as its output 224. In the pref~lled embodiment of Figure 11, the resistance of resistor 122b is equal to the r~si~t~nre of resistor 119, and the resistance of resistor 122a is equal to the reSict~n~e of resistor 120, to provide a gain for dirr~ellce amplifier 46 that equals the ratio of resistor 122b to resistor 122a.
Referring now to Figures 5 and 12, the comparator 47 and LED circuit 48 are shown in detail. The comparator circuit 47 pler~ilably comprises a comparator 126, a pull-up resistor 127, input resistor 124, and capacitor 125. The LBD circuit 48 includes an LED 131, l.dnsislur 130, current limiting resistors 128 and 129. The output of dirr~ Lial amplifier 46 preferably connects via conductor 224 to the inverting terminal of cu~ aldlol 126, through input resistor 124. The non-inverting input terminal of comparator 126 connects to ground, and to the inverting input terminal of comparator 126 through capacitor 125. The output of colllpal~lur 126 provides an input signal to the LED circuit 48 to turn on LED 131, or an alternative output device. Resistor 127 collll,l;ses a pull-up resistor which may be necessary if comparator 126 has an open-collector output stage. In CA 0226~984 1999-03-17 WO 98/11942 PCTtUS97/16319 the pl~felled embodiment, the output terminal of comparator 126 connects to the base termin:ll B
of transistor 130 through current limiting resistor 128. Power from the voltage source +Vcc is provided to LED 131 through resistor 129 when transistor 130 is turned on by the supply of sufficient base current from the comparator 126 to the base terminal B of the transistor 130.
Although an NPN lldll~ Ol iS shown in Figure 12, one of ordinary skill in the art will recognize that other types of LED driver circuits are possible, including the use of PNP ~Idnsi~lul~, and the present invention should not be construed as limited by the particular circuit embodiment shown in Figure 12. Similarly, although an LED 131 is shown as the output device, it will also be understand that other output devices, such as audible indications, may be used as an alternative, or in addition to LED 131.
An important parameter associated with a recharging system is charging efficiency.
Referring to Figure 2, recharging efficiency can be defined as the ratio of the electrical energy input to the charging system, Ejn~ in TET device 50 that is to the energy delivered to the battery, Ebatl in implantable device 14. Part of the energy coupled to the implanted device that is not delivered to the battery 13 is converted to thermal energy detrimentally heating the implanted device. Thus, it is desirable to maximize recharging efficiency in order to minimi7e lel~lpel~t~lre increases of the implantable device.
Referring now to Figure 13, it has been de~ il,ed that charging efficiency is a function of the m~gnih~ . of the charging current. Curve I exemplifies the efficiency when both capacitors 410 and 420 of implantable device 14 in Figure 2 are used in the charging circuit simlllt~n~.ously Improved efficiency can be achieved if either capacitor 410 or 420 is used, but not both simlllt~n~ ously. As shown in curve II, higher efficiency can be achieved using just capacitor 410 than using both capacitors together, but the ~rr,ciell~y still drops off at higher charging current levels.
If just capacitor 420 is used (curve III), higher efficiency is obtained at higher current levels, but lower efficiency at lower current levels than if just capacitor 410 is used. To m~ximi7e charging t;rrl~iel~y, therefore, it is preferable to use only capacitor 410 when charging at lower current levels and only capacitor 420 when charging at higher current levels, but not both capacitors sim~llt~n~oucly. Current level Io may be defined as the charging current above which capacitor 420 is used and below which capacitor 410 is used.
It should be noted that the secondary circuit in implantable device 14 can be properly tuned to the frequency of the AC current through the primary coil 9 by using either capacitor 410 or 420 in conjunction with secondary coil 10. That is, battery charging is possible regardless of which capacitor is included in the preferred embodiment. However, to achieve maximum efficiency, capacitor 410 preferably is used for low current charging and capacitor 420 is used for high current CA 0226~984 1999-03-17 charging. Accordingly, a mPchqni~m for switching the capacitors into the circuitry is described below.
Referring now to Figure 14, switches 411 and 421 of implantable device 14 are shown COII~ ,lelll with the preferred embodiment as MOSFET devices. Switch 421 effectively provides a S short circuit across capacitor 420 when switch 421 is closed and an open circuit when the switch is opened. Thus, opening switch 421 causes capacitor 420 to be used, which is preferable during high current charging periods (i.e., for geneldtil,g current I, in Figure 4B). Similarly, switch 411 can be opened, removing capacitor 410 from the charging circuit during high current charging. When switch 411 is closed, capacitor 410 forms part of the charging circuit, which is preferable during low current charging (for generating current l2 in Figure 4B). Preferably, switches 411 and 421 are opened for the duty cycle protocol of Figure 4C because only a single current level is generated.
Referring to Figure 14, the current sensor 270 (Figure 2) preferably Co~ liscs a current sensing resistor 435. As one of ordinary skill in the art will recognize, current sensing components typically include low r~ict~nfe resistors, such as 0.5Q resistors or less. Because one side of current sensing resistor 435 is grounded, the voltage on the other side at point S1 is proportional to the current through the resistor. Because the current sensing resistor is connected in series with the battery 13, the voltage at point S1 is proportional to the charging current applied to the battery.
Referring again to Figure 14, the voltage at point S1 (i.e., battery current) is provided as an input to switch drive logic 300. After filtering voltage S1 to remove high frequency noise, including ringing and carrier frequency, by low pass filter 440, the filtered signal is then amplified by inverting amplifier 445. Comparator 450 compares the amplified battery current signal to a reference voltage, VR, which is provided on line 447. The reference voltage y~ can be generated in several ways co~ ,Lent with the l~refe~l~,d embodiment. For example, voltage VR may be derived from the battery 13 through a voltage regulator. Reference voltage VR is predetermined so as to leplesellt the charging current level at which it is desired to switch from capacitor 410 to 420, or vice versa.
Preferably, VR is set to correspond to current level Io from Figure 13. One of ordinary skill in the art will also recognize the benefit in incorporating hysteresis into the comparator circuit 450 to prevent the comparator from oscillating if the amplified current signal S1 hovers around the value of the reference voltage VR. Low-pass filter 440, inverting amplifier 445, and comparator 450 can be provided by any of a number of conventional devices, and the present invention is not limited to any specific circuit implem~nt~tion.
Referring still to Figure 14, when the amplified current signal provided to the positive terminal of the culll~d,~tor 450 is greater than the r~ferel1ce voltage VR, the output of the CUIII~'dldtOI
on line 452 will become a logic high level. This high logic signal on line 452 in turn drives switches CA 0226~984 1999-03-17 411 and 421 open through inverting gate drives 455 and 457 which are of a type known to those of ordinary skill in the art. The low output signal of gate driver 455 on line 301 is provided to the gate terminal G of switch 411, thereby opening switch 411, and thus removing capacitor 410 from the circuit. Further, the low output signal of gate driver 457 on line 302 is provided to the gate terminal G of switch 421, thereby opening switch 421, and placing capacitor 420 in the charging circuit.
Therefore, for high charging currents over the trip point set by voltage VR (Io)~ charging efficiency is maximized by using only capacitor 420, not capacitor 410, in the charging circuit.
When charging the battery at a low current level (less than the trip point deffined by VR), the output signal on line 452 from the comparator 450 is driven to a low logic level because VR exceeds the output signal from inverting amplifier 445. The low logic level from the output of co~ al~tor 450 activates the inverting gate drives 455 and 457 to high output levels. A high output signal on line 301 from gate drive 455 closes switch 411 thereby placing capacitor 410 i~ltO the charging circuit. A high output signal on line 302 from gate drive 457 closes switch 421 and effectively removes capacitor 420 from the charging circuit. Therefore, for low charging currents (less than the trip point set by voltage VR), ~hal~i,lg efficiency is m~ximi7ed by using only capacitor 410, not capacitor 420, in the charging circuit.
Finally, referring to Figures 2 and 14, rectifier 12 preferably comprises a full-wave bridge rectifier including diodes 12a, 12b, 12c, and 12d. Capacitor 430 is provided as an output filter so that a good approximation to a DC level current is provided to battery 13.

Claims (26)

WHAT IS CLAIMED IS:
1. A transcutaneous energy transmission system for transmitting electrical power from an external charging device (51) to an implantable medical device (14) to recharge a battery (18) associated with the implantable device, said transcutaneous energy transmission system comprising:
an external charging device (51) containing a primary coil (9) for transmitting the power transcutaneously to said implantable device;
a capacitor (25) coupled to said primary coil, wherein said primary coil and said capacitor form a resonant circuit;
a controller (200) coupled to said resonant circuit by a first switch (21) and a second switch (22), said first switch and said second switch being alternatively switched on and off by said controller to produce a sinusoidal current waveform to said primary coil;
characterized by means (231. 232. 233) for controlling power radiated by said primary coil at at least a high level and a low level.
2. The device of claim 1 wherein said first switch (21) and said second switch (22) comprise solid state devices.
3. The device of claim 2 wherein said solid state switches (21, 22) comprise field effect transistors.
4. The device of claim 1 wherein said duty cycle is variable.
5. The device of any of the foregoing claims further characterized by said means (231, 232, 233) for contolling power uses a first duty cycle during an initial stage of charging and uses a second duty cycle during a subsequent stage of charging in which the second duty cycle is lower than the first duty cycle.
6. The device of claim 5, wherein the first duty cycle is 100%.
7. The device of claim 5, wherein the controller includes a first output terminal that couples to said primary coil.
8. The device of claim 7, wherein the controller (200) includes second and third output terminals connected to said first switch (21) and said second switch (22), respectively.
9. The device of claim 5, wherein the controller includes an enable signal, and the controller turns power on and off to the primary coil based upon the value of the enable signal.
10. The device as in claim 9, further comprising a pulse controller (231) for generating the enable signal.
11.

The system according to claim 1 wherein said means (231, 232, 233) for controlling said power is further characterized by timing means (231, 232, 233) for emitting pulses at at least a high and a low rate.
12. The system according to claim 11 wherein said timing means comprises circuitry (233) for generating a voltage signal with a varying amplitude;
a pulse width modulation controller (200) for controlling the level of charging current to said battery, said pulse width modulation controller comprising:
a pulse controller (231) providing a reference voltage signal;
a pulse generator (232) receiving said reference voltage signal and varying amplitude voltage signal, and in response generating an output pulse said output pulse having a width defined by the period when the varying amplitude voltage signal exceeds the reference voltage signal.
13. A device as in claim 12, wherein the varying amplitude voltage signal (Vc) exhibits a constantly repeating pattern.
14. A device as in claim 13 wherein the varying amplitude voltage signal (Vc) comprises a saw-tooth wave form.
15. A device as in claim 12 wherein the reference voltage signal (Vref) comprises one of two voltage levels. causing said pulse width modulation controller (200) to generate either a high charging current or a low charging current in said battery,
16. A device as in claim 15 wherein said high charging current is generated first followed by said low charging current.
17. A device as in claim 12, wherein said pulse width modulation controller (200) couples to said primary coil via a first switch (21) and a second switch (22), and wherein said pulse width modulation controller (200) transmits a first and second signal to turn on and off said first and second switch.
18. A device as in claim 17, wherein said first and second signals are alternately emitted to said first and second switches (21, 22) to generate said output pulse.
19. A device as in claim 18, further comprising a capacitor (25) connected to said primary coil (9) to form a resonant circuit.
20. A device as in claim 18, wherein said first and second switches (21, 22) comprise solid state switches.
21. A device as in claim 20, wherein said first and second signals comprise gate signals for said solid state switches (21, 22).
22. The transcutaneous energy transmission system according to any of the foregoing claims wherein said implantable medical device contains a secondary coil (10) in said implantable medical device;
a battery (18) for receiving electrical current from said secondary coil (10) a first capacitor (410) connected in parallel across said secondary coil (10);
a secondary capacitor (420) connected in series with said secondary coil (10);
further characterized by said first capacitor (410) being connected in series to a first switch (411). the combination of the first capacitor and first switch connected in parallel across said secondary coil;
and a second switch (421) connected in parallel across said second capacitor.
23. The system of claim 22, wherein the implantable medical device (14) further comprises a current sensor (270) for sensing the magnitude of current charging the battery.
24. The system of claim 23. wherein the implantable medical device further comprises a switch drive (300) for turning said first switch and said second switch on and off depending on the magnitude of current charging the battery, and wherein the magnitude of current charging the battery is indicated to the switch drive by the current sensor (270).
25. The system of claim 24, wherein said first switch (411) is closed to allow current to flow through said first capacitor (410) and said second switch (421) is closed to short circuit said second capacitor (420), when a relatively low charging current is applied to said battery (18).
26. The system of claim 24 wherein said first switch (411) is opened to prevent current from flowing through said first capacitor (410) and said second switch (421) is opened to allow current to flow through said second capacitor (420), when a relatively high charging current is applied to said battery (18).
CA002265984A 1996-09-17 1997-09-17 Enhanced transcutaneous recharging system for battery powered implantable medical device Abandoned CA2265984A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/710,449 1996-09-17
US08/710,449 US5702431A (en) 1995-06-07 1996-09-17 Enhanced transcutaneous recharging system for battery powered implantable medical device
PCT/US1997/016319 WO1998011942A1 (en) 1996-09-17 1997-09-17 Enhanced transcutaneous recharging system for battery powered implantable medical device

Publications (1)

Publication Number Publication Date
CA2265984A1 true CA2265984A1 (en) 1998-03-26

Family

ID=24854077

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002265984A Abandoned CA2265984A1 (en) 1996-09-17 1997-09-17 Enhanced transcutaneous recharging system for battery powered implantable medical device

Country Status (4)

Country Link
US (1) US5702431A (en)
EP (1) EP0934101A1 (en)
CA (1) CA2265984A1 (en)
WO (1) WO1998011942A1 (en)

Families Citing this family (297)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1666087A3 (en) * 1997-02-26 2009-04-29 The Alfred E Mann Foundation for Scientific Research Battery-powered patient implantable device
CA2297022A1 (en) * 1997-08-01 1999-02-11 Alfred E. Mann Foundation For Scientific Research Implantable device with improved battery recharging and powering configuration
US5991665A (en) * 1997-09-18 1999-11-23 Sulzer Intermedics Inc. Self-cooling transcutaneous energy transfer system for battery powered implantable device
DE19837913C2 (en) * 1998-08-20 2000-09-28 Implex Hear Tech Ag Implantable device with a charging current feed arrangement having a receiving coil
DE19838137A1 (en) 1998-08-21 2000-03-02 Implex Hear Tech Ag Charger arrangement for rechargeable Ni Cd, Ni-metal hydride, or Lithium batteries in implant, has current source which provides high initial current
JP2000081848A (en) * 1998-09-03 2000-03-21 Semiconductor Energy Lab Co Ltd Electronic equipment mounting liquid crystal display device
US6282449B1 (en) * 1998-10-21 2001-08-28 William Kamerling Method and device for causing the eye to focus on a near object
US6240318B1 (en) 1998-10-27 2001-05-29 Richard P. Phillips Transcutaneous energy transmission system with full wave Class E rectifier
US6635048B1 (en) 1999-04-30 2003-10-21 Medtronic, Inc. Implantable medical pump with multi-layer back-up memory
DE19930245A1 (en) 1999-06-25 2000-12-28 Biotronik Mess & Therapieg Electromedical implant
US6553263B1 (en) * 1999-07-30 2003-04-22 Advanced Bionics Corporation Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries
US6482145B1 (en) 2000-02-14 2002-11-19 Obtech Medical Ag Hydraulic anal incontinence treatment
US6471635B1 (en) 2000-02-10 2002-10-29 Obtech Medical Ag Anal incontinence disease treatment with controlled wireless energy supply
US6464628B1 (en) 1999-08-12 2002-10-15 Obtech Medical Ag Mechanical anal incontinence
US6503189B1 (en) 1999-08-12 2003-01-07 Obtech Medical Ag Controlled anal incontinence disease treatment
US6442434B1 (en) * 1999-10-19 2002-08-27 Abiomed, Inc. Methods and apparatus for providing a sufficiently stable power to a load in an energy transfer system
US6415186B1 (en) 2000-01-14 2002-07-02 Advanced Bionics Corporation Active feed forward power control loop
CA2398496C (en) * 2000-02-10 2009-05-19 Surgical Development Ag Urinary incontinence treatment with wireless energy supply
DE60135257D1 (en) 2000-02-10 2008-09-18 Potencia Medical Ag Mechanical device for impotence treatment
CN1202784C (en) 2000-02-10 2005-05-25 波滕西亚医疗公司 Controlled urinary incontinence treatment
CN1400888A (en) 2000-02-11 2003-03-05 波滕西亚医疗公司 Impotence treatment apparatus with energy transforming means
WO2001047440A2 (en) 2000-02-14 2001-07-05 Potencia Medical Ag Male impotence prosthesis apparatus with wireless energy supply
ATE296071T1 (en) 2000-02-14 2005-06-15 Potencia Medical Ag PENIS PROSTHESIS
US20030100929A1 (en) 2000-02-14 2003-05-29 Peter Forsell Controlled penile prosthesis
DE10016520A1 (en) 2000-04-03 2001-10-11 Implex Hear Tech Ag Implantable energy storage arrangement for a medical implant and operating method therefor
DE10016519A1 (en) 2000-04-03 2001-10-11 Implex Hear Tech Ag Implantable energy storage arrangement for a medical implant and operating method therefor
US6458164B1 (en) 2000-04-25 2002-10-01 The Penn State Research Foundation Artificial heart with energy recovery
US6478820B1 (en) 2000-04-25 2002-11-12 The Penn State Research Foundation Artificial heart with synchronous rectification
US6395027B1 (en) 2000-04-25 2002-05-28 The Penn State Research Foundation Artificial heart with arrhythmia signalling
US6451055B1 (en) 2000-04-25 2002-09-17 The Penn State Research Foundation Artificial heart data communication system
US6579315B1 (en) 2000-04-25 2003-06-17 The Penn State Research Foundation Artificial heart power supply system
US6456883B1 (en) * 2000-04-26 2002-09-24 Medtronic, Inc. Apparatus and method for allowing immediate retrieval for information and identification from an implantable medical device having a depleted power source
US7167756B1 (en) 2000-04-28 2007-01-23 Medtronic, Inc. Battery recharge management for an implantable medical device
US6327504B1 (en) 2000-05-10 2001-12-04 Thoratec Corporation Transcutaneous energy transfer with circuitry arranged to avoid overheating
DE04078528T1 (en) * 2000-07-26 2005-09-01 Advanced Bionics Corp., Sylmar Rechargeable stimulation system
DE10041727C2 (en) * 2000-08-25 2003-04-10 Cochlear Ltd Implantable hermetically sealed housing for an implantable medical device
AUPR036600A0 (en) * 2000-09-26 2000-10-19 Cochlear Limited Multiple battery management system
US6621718B1 (en) * 2000-11-22 2003-09-16 International Business Machines Corporation Resonant converter circuit
US6707920B2 (en) 2000-12-12 2004-03-16 Otologics Llc Implantable hearing aid microphone
US7151378B2 (en) * 2001-09-25 2006-12-19 Wilson Greatbatch Technologies, Inc. Implantable energy management system and method
US7254449B2 (en) * 2002-07-31 2007-08-07 Advanced Bionics Corp Systems and methods for providing power to one or more implantable devices
US7248926B2 (en) * 2002-08-30 2007-07-24 Advanced Bionics Corporation Status indicator for implantable systems
US7349741B2 (en) * 2002-10-11 2008-03-25 Advanced Bionics, Llc Cochlear implant sound processor with permanently integrated replenishable power source
US7076304B2 (en) * 2003-04-07 2006-07-11 Kidney Replacement Services P.C. Transcutaneous power supply
AU2003901730A0 (en) * 2003-04-11 2003-05-01 Cochlear Limited Power management system
US7570994B2 (en) * 2003-04-25 2009-08-04 Medtronic Physio-Control Corp. Apparatus and method for maintaining a defibrillator battery charge and optionally communicating
US7599508B1 (en) 2003-05-08 2009-10-06 Advanced Bionics, Llc Listening device cap
US8270647B2 (en) 2003-05-08 2012-09-18 Advanced Bionics, Llc Modular speech processor headpiece
US8811643B2 (en) 2003-05-08 2014-08-19 Advanced Bionics Integrated cochlear implant headpiece
AU2003903839A0 (en) * 2003-07-24 2003-08-07 Cochlear Limited Battery characterisation
US7813809B2 (en) 2004-06-10 2010-10-12 Medtronic, Inc. Implantable pulse generator for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US20050102006A1 (en) * 2003-09-25 2005-05-12 Whitehurst Todd K. Skull-mounted electrical stimulation system
US20050075696A1 (en) 2003-10-02 2005-04-07 Medtronic, Inc. Inductively rechargeable external energy source, charger, system and method for a transcutaneous inductive charger for an implantable medical device
US8140168B2 (en) * 2003-10-02 2012-03-20 Medtronic, Inc. External power source for an implantable medical device having an adjustable carrier frequency and system and method related therefore
US7225032B2 (en) * 2003-10-02 2007-05-29 Medtronic Inc. External power source, charger and system for an implantable medical device having thermal characteristics and method therefore
US9259584B2 (en) 2003-10-02 2016-02-16 Medtronic, Inc. External unit for implantable medical device coupled by cord
US8346361B2 (en) * 2003-10-02 2013-01-01 Medtronic, Inc. User interface for external charger for implantable medical device
US7308316B2 (en) * 2003-10-02 2007-12-11 Medtronic, Inc. Storable implantable medical device assembly allowing in package charging
US7556597B2 (en) * 2003-11-07 2009-07-07 Otologics, Llc Active vibration attenuation for implantable microphone
US7204799B2 (en) * 2003-11-07 2007-04-17 Otologics, Llc Microphone optimized for implant use
DE10353943B4 (en) * 2003-11-18 2013-01-03 Deutsches Zentrum für Luft- und Raumfahrt e.V. Arrangement for the wireless transmission of energy to an implanted device
GB0329019D0 (en) * 2003-12-15 2004-01-14 Imp College Innovations Ltd Acoustic wave devices
EP1557949A1 (en) * 2004-01-23 2005-07-27 Matsushita Electric Industrial Co., Ltd. Low-noise differential bias circuit and differential signal processing apparatus
US8467875B2 (en) 2004-02-12 2013-06-18 Medtronic, Inc. Stimulation of dorsal genital nerves to treat urologic dysfunctions
US7840020B1 (en) 2004-04-01 2010-11-23 Otologics, Llc Low acceleration sensitivity microphone
US7214179B2 (en) * 2004-04-01 2007-05-08 Otologics, Llc Low acceleration sensitivity microphone
US7212110B1 (en) * 2004-04-19 2007-05-01 Advanced Neuromodulation Systems, Inc. Implantable device and system and method for wireless communication
US9205255B2 (en) 2004-06-10 2015-12-08 Medtronic Urinary Solutions, Inc. Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US9308382B2 (en) 2004-06-10 2016-04-12 Medtronic Urinary Solutions, Inc. Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US7761167B2 (en) 2004-06-10 2010-07-20 Medtronic Urinary Solutions, Inc. Systems and methods for clinician control of stimulation systems
US8165692B2 (en) 2004-06-10 2012-04-24 Medtronic Urinary Solutions, Inc. Implantable pulse generator power management
US8195304B2 (en) 2004-06-10 2012-06-05 Medtronic Urinary Solutions, Inc. Implantable systems and methods for acquisition and processing of electrical signals
US20050288740A1 (en) * 2004-06-24 2005-12-29 Ethicon Endo-Surgery, Inc. Low frequency transcutaneous telemetry to implanted medical device
US20050288739A1 (en) 2004-06-24 2005-12-29 Ethicon, Inc. Medical implant having closed loop transcutaneous energy transfer (TET) power transfer regulation circuitry
US7599743B2 (en) 2004-06-24 2009-10-06 Ethicon Endo-Surgery, Inc. Low frequency transcutaneous energy transfer to implanted medical device
US7599744B2 (en) 2004-06-24 2009-10-06 Ethicon Endo-Surgery, Inc. Transcutaneous energy transfer primary coil with a high aspect ferrite core
US7878207B2 (en) * 2004-07-20 2011-02-01 Medtronic, Inc. Locating an implanted object based on external antenna loading
US20060085051A1 (en) * 2004-10-19 2006-04-20 Fritsch Michael H Electrical implants
US7632235B1 (en) 2004-11-22 2009-12-15 Pacesetter, Inc. System and method for measuring cardiac output via thermal dilution using an implantable medical device with an external ultrasound power delivery system
US7190153B2 (en) 2004-12-01 2007-03-13 Alfred E. Mann Foundation For Scientific Research System, circuit and method for tuning a resonant circuit
WO2006076531A2 (en) * 2005-01-11 2006-07-20 Otologics, Llc Active vibration attenuation for implantable microphone
US8096937B2 (en) 2005-01-11 2012-01-17 Otologics, Llc Adaptive cancellation system for implantable hearing instruments
US7775966B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. Non-invasive pressure measurement in a fluid adjustable restrictive device
US7658196B2 (en) 2005-02-24 2010-02-09 Ethicon Endo-Surgery, Inc. System and method for determining implanted device orientation
US7699770B2 (en) 2005-02-24 2010-04-20 Ethicon Endo-Surgery, Inc. Device for non-invasive measurement of fluid pressure in an adjustable restriction device
US8016744B2 (en) 2005-02-24 2011-09-13 Ethicon Endo-Surgery, Inc. External pressure-based gastric band adjustment system and method
US7775215B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. System and method for determining implanted device positioning and obtaining pressure data
US7927270B2 (en) 2005-02-24 2011-04-19 Ethicon Endo-Surgery, Inc. External mechanical pressure sensor for gastric band pressure measurements
US8066629B2 (en) 2005-02-24 2011-11-29 Ethicon Endo-Surgery, Inc. Apparatus for adjustment and sensing of gastric band pressure
US7565204B2 (en) * 2005-03-24 2009-07-21 Alfred E. Mann Foundation For Scientific Research Implantable device for controlling received power by a power receiving unit therein
US7502594B2 (en) * 2005-04-27 2009-03-10 Codman Neuro Sciences Sárl Power regulation feedback to optimize robustness of wireless transmissions
US7774069B2 (en) * 2005-04-29 2010-08-10 Medtronic, Inc. Alignment indication for transcutaneous energy transfer
US7505816B2 (en) * 2005-04-29 2009-03-17 Medtronic, Inc. Actively cooled external energy source, external charger, system of transcutaneous energy transfer, system of transcutaneous charging and method therefore
US7489793B2 (en) * 2005-07-08 2009-02-10 Otologics, Llc Implantable microphone with shaped chamber
US7522738B2 (en) * 2005-11-30 2009-04-21 Otologics, Llc Dual feedback control system for implantable hearing instrument
ATE476224T1 (en) * 2005-12-07 2010-08-15 Boston Scient Neuromodulation BATTERY PROTECTION AND ZERO VOLT BATTERY RECHARGE SYSTEM FOR AN IMPLANTABLE MEDICAL DEVICE
US7813801B2 (en) * 2005-12-15 2010-10-12 Cardiac Pacemakers, Inc. Implantable medical device powered by rechargeable battery
US8870742B2 (en) 2006-04-06 2014-10-28 Ethicon Endo-Surgery, Inc. GUI for an implantable restriction device and a data logger
US8152710B2 (en) 2006-04-06 2012-04-10 Ethicon Endo-Surgery, Inc. Physiological parameter analysis for an implantable restriction device and a data logger
CN100386916C (en) * 2006-04-28 2008-05-07 清华大学 Wireless charging device through skin in use for implantation type medical treatment instrument
US9480846B2 (en) * 2006-05-17 2016-11-01 Medtronic Urinary Solutions, Inc. Systems and methods for patient control of stimulation systems
EP2069019A2 (en) * 2006-09-25 2009-06-17 Koninklijke Philips Electronics N.V. Feedback loop for focused ultrasound application
US7881803B2 (en) * 2006-10-18 2011-02-01 Boston Scientific Neuromodulation Corporation Multi-electrode implantable stimulator device with a single current path decoupling capacitor
US20080103572A1 (en) 2006-10-31 2008-05-01 Medtronic, Inc. Implantable medical lead with threaded fixation
EP1936541B1 (en) * 2006-12-22 2017-08-30 EM Microelectronic-Marin SA On/off battery charger with power supply protection for monolithic integrated circuits using the energy from the antenna
CN100576711C (en) * 2007-03-29 2009-12-30 雅米科技股份有限公司 Induction power system
US7932696B2 (en) * 2007-05-14 2011-04-26 Boston Scientific Neuromodulation Corporation Charger alignment indicator with adjustable threshold
US8021496B2 (en) * 2007-05-16 2011-09-20 Fmc Corporation Stabilized lithium metal powder for Li-ion application, composition and process
US8901878B2 (en) * 2007-06-05 2014-12-02 Impulse Dynamics Nv Transcutaneous charging device
EP2211768B1 (en) 2007-10-11 2021-03-24 Implantica Patent Ltd. Apparatus for controlling flow in a bodily organ
US8696543B2 (en) 2007-10-11 2014-04-15 Kirk Promotion Ltd. Method for controlling flow of intestinal contents in a patient's intestines
US8992409B2 (en) 2007-10-11 2015-03-31 Peter Forsell Method for controlling flow in a bodily organ
US8795153B2 (en) 2007-10-11 2014-08-05 Peter Forsell Method for treating female sexual dysfunction
EP3973923A1 (en) * 2007-10-11 2022-03-30 Implantica Patent Ltd. A device for the treatment of aneurysm
WO2009048401A1 (en) * 2007-10-11 2009-04-16 Milux Holding Sa A method for the treatment of aneurysm
JP2011500203A (en) * 2007-10-16 2011-01-06 ミルックス・ホールディング・エスエイ Method and apparatus for supplying energy to a medical device
EP2211989A4 (en) * 2007-10-16 2016-01-20 Kirk Promotion Ltd A method and apparatus for supplying energy to a medical device
US9452296B2 (en) 2007-10-16 2016-09-27 Peter Forsell Method and system for controlling supply of energy to an implantable medical device
US8472654B2 (en) 2007-10-30 2013-06-25 Cochlear Limited Observer-based cancellation system for implantable hearing instruments
AU2008330254B2 (en) * 2007-11-27 2015-05-28 Implantica Patent Ltd. Energy transfer control adapted to a medical device system
US8187163B2 (en) 2007-12-10 2012-05-29 Ethicon Endo-Surgery, Inc. Methods for implanting a gastric restriction device
US8100870B2 (en) 2007-12-14 2012-01-24 Ethicon Endo-Surgery, Inc. Adjustable height gastric restriction devices and methods
US8142452B2 (en) 2007-12-27 2012-03-27 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8377079B2 (en) 2007-12-27 2013-02-19 Ethicon Endo-Surgery, Inc. Constant force mechanisms for regulating restriction devices
US8337389B2 (en) 2008-01-28 2012-12-25 Ethicon Endo-Surgery, Inc. Methods and devices for diagnosing performance of a gastric restriction system
EP3964243A1 (en) * 2008-01-28 2022-03-09 Implantica Patent Ltd Blood clot removal device, system, and method
US8192350B2 (en) 2008-01-28 2012-06-05 Ethicon Endo-Surgery, Inc. Methods and devices for measuring impedance in a gastric restriction system
US8591395B2 (en) 2008-01-28 2013-11-26 Ethicon Endo-Surgery, Inc. Gastric restriction device data handling devices and methods
BRPI0906746A8 (en) 2008-01-29 2019-05-14 Implantica Patent Ltd apparatus for treating gastresophageal reflux disease
US7844342B2 (en) 2008-02-07 2010-11-30 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using light
US8221439B2 (en) 2008-02-07 2012-07-17 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using kinetic motion
US8114345B2 (en) 2008-02-08 2012-02-14 Ethicon Endo-Surgery, Inc. System and method of sterilizing an implantable medical device
US8591532B2 (en) 2008-02-12 2013-11-26 Ethicon Endo-Sugery, Inc. Automatically adjusting band system
US8057492B2 (en) 2008-02-12 2011-11-15 Ethicon Endo-Surgery, Inc. Automatically adjusting band system with MEMS pump
US8034065B2 (en) 2008-02-26 2011-10-11 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8187162B2 (en) 2008-03-06 2012-05-29 Ethicon Endo-Surgery, Inc. Reorientation port
US8233995B2 (en) 2008-03-06 2012-07-31 Ethicon Endo-Surgery, Inc. System and method of aligning an implantable antenna
US8332040B1 (en) 2008-03-10 2012-12-11 Advanced Neuromodulation Systems, Inc. External charging device for charging an implantable medical device and methods of regulating duty of cycle of an external charging device
US8509909B2 (en) 2008-04-10 2013-08-13 Medtronic, Inc. Using telemetry coupling as a surrogate for recharger coupling
US8509912B2 (en) 2008-04-30 2013-08-13 Medtronic, Inc. External power source, system and method for predicting heat loss of implantable medical device during inductive recharging by external primary coil
US8179087B2 (en) * 2008-06-02 2012-05-15 Physio-Control, Inc. Selective recharging of medical device depending on authentication of power adapter system
US9008766B2 (en) 2008-06-02 2015-04-14 Physio-Control, Inc. Medical device adjusting operation when used with non-authenticated patient parameter collecting accessory
US8183823B2 (en) * 2008-06-02 2012-05-22 Physio-Control, Inc. Selective powering of medical device depending on authentication of power adapter system
CN102204074B (en) * 2008-09-11 2016-03-16 奥克兰联合服务有限公司 Inductively AC energy transmission
US8874215B2 (en) 2008-10-10 2014-10-28 Peter Forsell System, an apparatus, and a method for treating a sexual dysfunctional female patient
WO2010042054A1 (en) * 2008-10-10 2010-04-15 Milux Holding S.A. Charger for implant
US9320909B2 (en) 2008-10-10 2016-04-26 Peter Forsell Accessory for an implant
EP4258513A3 (en) 2008-10-10 2023-10-25 Implantica Patent Ltd. Charger for implant
EP2349096B1 (en) 2008-10-10 2021-01-27 MedicalTree Patent Ltd. An improved artificial valve
WO2010042057A1 (en) * 2008-10-10 2010-04-15 Milux Holding S.A. Charger for implant
EP2346570B1 (en) * 2008-10-10 2016-10-12 Kirk Promotion LTD. System for transferring information between an implant and an external device
ES2950024T3 (en) 2008-10-10 2023-10-04 Medicaltree Patent Ltd Heart support device, system and procedure
US11123171B2 (en) 2008-10-10 2021-09-21 Peter Forsell Fastening means for implantable medical control assembly
US9072907B2 (en) 2008-10-10 2015-07-07 Peter Forsell Heart help device, system, and method
WO2010042056A1 (en) * 2008-10-10 2010-04-15 Milux Holding S.A. Charger for implant with means for indicating alignment between charger and implant
EP2349170B1 (en) 2008-10-10 2023-09-27 Implantica Patent Ltd. Apparatus for the treatment of female sexual dysfunction
US9631610B2 (en) * 2008-12-04 2017-04-25 Deep Science, Llc System for powering devices from intraluminal pressure changes
US9759202B2 (en) * 2008-12-04 2017-09-12 Deep Science, Llc Method for generation of power from intraluminal pressure changes
US9567983B2 (en) 2008-12-04 2017-02-14 Deep Science, Llc Method for generation of power from intraluminal pressure changes
US9353733B2 (en) * 2008-12-04 2016-05-31 Deep Science, Llc Device and system for generation of power from intraluminal pressure changes
US9526418B2 (en) * 2008-12-04 2016-12-27 Deep Science, Llc Device for storage of intraluminally generated power
US8271089B2 (en) * 2009-04-03 2012-09-18 Medtronic, Inc. Hybrid rectification for recharging an implantable medical device
US8214042B2 (en) * 2009-05-26 2012-07-03 Boston Scientific Neuromodulation Corporation Techniques for controlling charging of batteries in an external charger and an implantable medical device
WO2010138911A1 (en) 2009-05-29 2010-12-02 Otologics, Llc Implantable auditory stimulation system and method with offset implanted microphones
US20100305663A1 (en) * 2009-06-02 2010-12-02 Boston Scientific Neuromodulation Corporation Implantable medical device system having short range communication link between an external controller and an external charger
JP4915600B2 (en) * 2009-06-25 2012-04-11 パナソニック株式会社 Rechargeable electrical equipment
US20100331919A1 (en) * 2009-06-30 2010-12-30 Boston Scientific Neuromodulation Corporation Moldable charger having hinged sections for charging an implantable pulse generator
US8260432B2 (en) 2009-06-30 2012-09-04 Boston Scientific Neuromodulation Corporation Moldable charger with shape-sensing means for an implantable pulse generator
US20100331918A1 (en) * 2009-06-30 2010-12-30 Boston Scientific Neuromodulation Corporation Moldable charger with curable material for charging an implantable pulse generator
US9399131B2 (en) * 2009-06-30 2016-07-26 Boston Scientific Neuromodulation Corporation Moldable charger with support members for charging an implantable pulse generator
US10952836B2 (en) 2009-07-17 2021-03-23 Peter Forsell Vaginal operation method for the treatment of urinary incontinence in women
US9949812B2 (en) 2009-07-17 2018-04-24 Peter Forsell Vaginal operation method for the treatment of anal incontinence in women
US9782600B2 (en) * 2009-08-20 2017-10-10 Envoy Medical Corporation Self-regulating transcutaneous energy transfer
US8321029B2 (en) 2009-09-18 2012-11-27 Boston Scientific Neuromodulation Corporation External charger usable with an implantable medical device having a programmable or time-varying temperature set point
US10751537B2 (en) 2009-10-20 2020-08-25 Nyxoah SA Arced implant unit for modulation of nerves
US9409013B2 (en) 2009-10-20 2016-08-09 Nyxoah SA Method for controlling energy delivery as a function of degree of coupling
US10716940B2 (en) 2009-10-20 2020-07-21 Nyxoah SA Implant unit for modulation of small diameter nerves
WO2011097289A1 (en) * 2010-02-03 2011-08-11 Medtronic, Inc. Implantable medical devices and systems having dual frequency inductive telemetry and recharge
US9042995B2 (en) * 2010-02-03 2015-05-26 Medtronic, Inc. Implantable medical devices and systems having power management for recharge sessions
US8594806B2 (en) 2010-04-30 2013-11-26 Cyberonics, Inc. Recharging and communication lead for an implantable device
US8779777B2 (en) * 2010-06-04 2014-07-15 Linear Technology Corporation Dynamic compensation of aging drift in current sense resistor
US8344697B2 (en) * 2010-08-02 2013-01-01 GM Global Technlogy Operations LLC Method for optimized design and operation of battery cooling system in electric vehicles
US8441305B2 (en) * 2010-08-30 2013-05-14 Analog Devices, Inc. Low-leakage diodes and methods of forming the same
US8901775B2 (en) 2010-12-10 2014-12-02 Everheart Systems, Inc. Implantable wireless power system
US9496924B2 (en) 2010-12-10 2016-11-15 Everheart Systems, Inc. Mobile wireless power system
DK2654878T3 (en) 2010-12-20 2019-07-22 Abiomed Inc TRANSCUTANT ENERGY TRANSFER SYSTEM WITH A MULTIPLE OF SECONDARY COILS
WO2012087819A2 (en) 2010-12-20 2012-06-28 Abiomed, Inc. Transcutaneous energy transfer system with vibration inducing warning circuitry
WO2012087816A2 (en) 2010-12-20 2012-06-28 Abiomed, Inc. Method and apparatus for accurately tracking available charge in a transcutaneous energy transfer system
EP4119184A1 (en) 2011-04-14 2023-01-18 Abiomed, Inc. Transcutaneous energy transfer coil with integrated radio frequency antenna
US9136728B2 (en) 2011-04-28 2015-09-15 Medtronic, Inc. Implantable medical devices and systems having inductive telemetry and recharge on a single coil
US9531195B2 (en) 2011-04-29 2016-12-27 Cyberonics, Inc. Inductively rechargeable implantable device with reduced eddy currents
US8401664B2 (en) 2011-04-29 2013-03-19 Cyberonics, Inc. System and method for charging a power cell in an implantable medical device
US8764621B2 (en) 2011-07-11 2014-07-01 Vascor, Inc. Transcutaneous power transmission and communication for implanted heart assist and other devices
US9393433B2 (en) 2011-07-20 2016-07-19 Boston Scientific Neuromodulation Corporation Battery management for an implantable medical device
US10500394B1 (en) 2011-10-11 2019-12-10 A-Hamid Hakki Pacemaker system equipped with a flexible intercostal generator
US9446254B2 (en) * 2011-10-13 2016-09-20 Boston Scientific Neuromodulation Corporation Charger alignment in an implantable medical device system employing reflected impedance modulation
US9002468B2 (en) 2011-12-16 2015-04-07 Abiomed, Inc. Automatic power regulation for transcutaneous energy transfer charging system
US9099938B2 (en) * 2011-12-16 2015-08-04 Empower Micro Systems Bi-directional energy converter with multiple DC sources
US10682520B2 (en) 2012-01-27 2020-06-16 Medtronic, Inc. Managing recharge power for implantable medical devices
US9270134B2 (en) * 2012-01-27 2016-02-23 Medtronic, Inc. Adaptive rate recharging system
US9393420B2 (en) 2012-03-09 2016-07-19 Enteromedics Inc. Safety features for use in medical devices
WO2013138451A1 (en) * 2012-03-13 2013-09-19 Sunshine Heart Company Pty Ltd Methods, systems, and devices relating to wireless power transfer
AU2013232107B2 (en) * 2012-03-16 2015-11-19 Boston Scientific Neuromodulation Corporation Neurostimulation system for preventing magnetically induced currents in electronic circuitry
US11253712B2 (en) 2012-07-26 2022-02-22 Nyxoah SA Sleep disordered breathing treatment apparatus
US9907967B2 (en) 2012-07-26 2018-03-06 Adi Mashiach Transcutaneous power conveyance device
US10052097B2 (en) 2012-07-26 2018-08-21 Nyxoah SA Implant unit delivery tool
AU2013294705B2 (en) 2012-07-26 2018-02-01 Nyxoah SA Implant sleep apnea treatment device including an antenna
WO2014018971A1 (en) 2012-07-27 2014-01-30 Thoratec Corporation Resonant power transfer systems with protective algorithm
US10525181B2 (en) 2012-07-27 2020-01-07 Tc1 Llc Resonant power transfer system and method of estimating system state
US9805863B2 (en) 2012-07-27 2017-10-31 Thoratec Corporation Magnetic power transmission utilizing phased transmitter coil arrays and phased receiver coil arrays
EP2878062A4 (en) 2012-07-27 2016-04-20 Thoratec Corp Resonant power transmission coils and systems
US10383990B2 (en) 2012-07-27 2019-08-20 Tc1 Llc Variable capacitor for resonant power transfer systems
WO2014018972A1 (en) 2012-07-27 2014-01-30 Thoratec Corporation Computer modeling for resonant power transfer systems
US9592397B2 (en) 2012-07-27 2017-03-14 Thoratec Corporation Thermal management for implantable wireless power transfer systems
US9287040B2 (en) 2012-07-27 2016-03-15 Thoratec Corporation Self-tuning resonant power transfer systems
US9343923B2 (en) 2012-08-23 2016-05-17 Cyberonics, Inc. Implantable medical device with backscatter signal based communication
EP2891239B1 (en) 2012-08-31 2019-02-13 The Alfred E. Mann Foundation for Scientific Research Feedback controlled coil driver for inductive power transfer
US9225190B2 (en) * 2012-09-07 2015-12-29 Manufacturers And Traders Trust Company Implant current controlled battery charging based on temperature
US9209634B2 (en) 2012-09-07 2015-12-08 Greatbatch Ltd. Method of improving battery recharge efficiency by statistical analysis
US9935498B2 (en) 2012-09-25 2018-04-03 Cyberonics, Inc. Communication efficiency with an implantable medical device using a circulator and a backscatter signal
CN104854771B (en) 2012-10-29 2019-07-19 苹果公司 The receiver of induction power Transmission system and method for controlling the receiver
US9872997B2 (en) 2013-03-15 2018-01-23 Globus Medical, Inc. Spinal cord stimulator system
US9440076B2 (en) 2013-03-15 2016-09-13 Globus Medical, Inc. Spinal cord stimulator system
AU2014232252B2 (en) 2013-03-15 2018-01-18 Alfred E. Mann Foundation For Scientific Research Current sensing multiple output current stimulators with fast turn on time
US9887574B2 (en) 2013-03-15 2018-02-06 Globus Medical, Inc. Spinal cord stimulator system
US9680310B2 (en) 2013-03-15 2017-06-13 Thoratec Corporation Integrated implantable TETS housing including fins and coil loops
WO2014145895A1 (en) 2013-03-15 2014-09-18 Thoratec Corporation Malleable tets coil with improved anatomical fit
AU2014232255B2 (en) 2013-03-15 2017-08-31 Alfred E. Mann Foundation For Scientific Research High voltage monitoring successive approximation analog to digital converter
US9878170B2 (en) 2013-03-15 2018-01-30 Globus Medical, Inc. Spinal cord stimulator system
JP6702856B2 (en) 2013-05-03 2020-06-03 アルフレッド イー. マン ファウンデーション フォー サイエンティフィック リサーチ Reliable wire welding for embedded devices
CN105658276B (en) 2013-05-03 2018-10-02 艾尔弗雷德·E·曼科学研究基金会 Implantation material recharger is shaken hands system and method
WO2014179811A1 (en) 2013-05-03 2014-11-06 Alfred E. Mann Foundation For Scientific Research Multi-branch stimulation electrode for subcutaneous field stimulation
EP3010583B1 (en) 2013-06-17 2020-08-05 Nyxoah SA Dynamic modification of modulation throughout a therapy period
AU2014296322B2 (en) 2013-07-29 2020-01-16 Alfred E. Mann Foundation For Scientific Research High efficiency magnetic link for implantable devices
US9780596B2 (en) 2013-07-29 2017-10-03 Alfred E. Mann Foundation For Scientific Research Microprocessor controlled class E driver
EP3028365A1 (en) 2013-07-29 2016-06-08 Alfred E. Mann Foundation for Scientific Research Implant charging field control through radio link
EP3069358B1 (en) 2013-11-11 2019-06-12 Tc1 Llc Hinged resonant power transfer coil
US10615642B2 (en) 2013-11-11 2020-04-07 Tc1 Llc Resonant power transfer systems with communications
US10695476B2 (en) 2013-11-11 2020-06-30 Tc1 Llc Resonant power transfer systems with communications
US9270137B2 (en) * 2014-02-07 2016-02-23 Advanced Neuromodulation Systems, Inc. System and method for controlling charging energy delivered to an implantable medical device
US9345883B2 (en) 2014-02-14 2016-05-24 Boston Scientific Neuromodulation Corporation Rechargeable-battery implantable medical device having a primary battery active during a rechargeable-battery undervoltage condition
WO2015134871A1 (en) 2014-03-06 2015-09-11 Thoratec Corporation Electrical connectors for implantable devices
WO2015171869A1 (en) * 2014-05-08 2015-11-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Neural stimulator
US11103715B2 (en) * 2014-06-27 2021-08-31 Cochlear Limited Devices and methods for charging medical devices
DE102015112097A1 (en) 2014-07-25 2016-01-28 Minnetronix, Inc. power scale
DE102015112098A1 (en) 2014-07-25 2016-01-28 Minnetronix, Inc. Coil parameters and control
CA2958199C (en) 2014-08-15 2023-03-07 Axonics Modulation Technologies, Inc. Electromyographic lead positioning and stimulation titration in a nerve stimulation system for treatment of overactive bladder
US9802038B2 (en) 2014-08-15 2017-10-31 Axonics Modulation Technologies, Inc. Implantable lead affixation structure for nerve stimulation to alleviate bladder dysfunction and other indication
JP6878269B2 (en) 2014-08-15 2021-05-26 アクソニクス モジュレーション テクノロジーズ インコーポレイテッド Systems and Methods for Nerve Stimulation Electrode Configuration Based on Nerve Positioning
US10682521B2 (en) 2014-08-15 2020-06-16 Axonics Modulation Technologies, Inc. Attachment devices and associated methods of use with a nerve stimulation charging device
EP3180071B1 (en) 2014-08-15 2021-09-22 Axonics, Inc. External pulse generator device and associated system for trial nerve stimulation
WO2016025915A1 (en) 2014-08-15 2016-02-18 Axonics Modulation Technologies, Inc. Integrated electromyographic clinician programmer for use with an implantable neurostimulator
US9539435B2 (en) 2014-09-08 2017-01-10 Medtronic, Inc. Transthoracic protection circuit for implantable medical devices
US9861827B2 (en) 2014-09-08 2018-01-09 Medtronic, Inc. Implantable medical devices having multi-cell power sources
US9604071B2 (en) 2014-09-08 2017-03-28 Medtronic, Inc. Implantable medical devices having multi-cell power sources
US9724528B2 (en) 2014-09-08 2017-08-08 Medtronic, Inc. Multiple transformer charging circuits for implantable medical devices
US9643025B2 (en) 2014-09-08 2017-05-09 Medtronic, Inc. Multi-primary transformer charging circuits for implantable medical devices
US9861828B2 (en) 2014-09-08 2018-01-09 Medtronic, Inc. Monitoring multi-cell power source of an implantable medical device
US9579517B2 (en) 2014-09-08 2017-02-28 Medtronic, Inc. Transformer-based charging circuits for implantable medical devices
EP3198677B1 (en) 2014-09-22 2021-03-03 Tc1 Llc Antenna designs for communication between a wirelessly powered implant to an external device outside the body
US9583874B2 (en) 2014-10-06 2017-02-28 Thoratec Corporation Multiaxial connector for implantable devices
US9916436B2 (en) 2014-10-24 2018-03-13 Physio-Control, Inc. Intelligent accessories for medical devices
KR102434241B1 (en) 2014-11-05 2022-08-18 애플 인크. An inductive power receiver
EP3242712B1 (en) 2015-01-09 2019-04-10 Axonics Modulation Technologies, Inc. Patient remote and associated methods of use with a nerve stimulation system
CN107427685B (en) 2015-01-09 2021-09-21 艾克索尼克斯股份有限公司 Attachment devices for use with neurostimulation charging devices and associated methods
CN107427683B (en) 2015-01-09 2019-06-21 艾克索尼克斯调制技术股份有限公司 For can plant the improvement antenna and application method of nerve stimulator
US10342908B2 (en) 2015-01-14 2019-07-09 Minnetronix, Inc. Distributed transformer
US10406267B2 (en) 2015-01-16 2019-09-10 Minnetronix, Inc. Data communication in a transcutaneous energy transfer system
JP2016174469A (en) * 2015-03-17 2016-09-29 株式会社東芝 Charging relay device and charging relay method
DE102016106657A1 (en) 2015-04-14 2016-10-20 Minnetronix, Inc. REPEATER RESONANCE CIRCUIT
US10284968B2 (en) 2015-05-21 2019-05-07 Cochlear Limited Advanced management of an implantable sound management system
JP6946261B2 (en) 2015-07-10 2021-10-06 アクソニクス インコーポレイテッド Implantable nerve stimulators and methods with internal electronics without ASICs
US10148126B2 (en) 2015-08-31 2018-12-04 Tc1 Llc Wireless energy transfer system and wearables
EP3902100A1 (en) 2015-10-07 2021-10-27 Tc1 Llc Resonant power transfer systems having efficiency optimization based on receiver impedance
US9931515B2 (en) * 2015-12-17 2018-04-03 Novartis Ag Powered case for electro-active medical device battery management
US9517338B1 (en) 2016-01-19 2016-12-13 Axonics Modulation Technologies, Inc. Multichannel clip device and methods of use
US10195423B2 (en) 2016-01-19 2019-02-05 Axonics Modulation Technologies, Inc. Multichannel clip device and methods of use
JP6876363B2 (en) 2016-01-29 2021-05-26 アクソニクス モジュレーション テクノロジーズ インコーポレイテッド Methods and systems for frequency adjustment that optimize the charging of implantable neurostimulators
WO2017139784A1 (en) 2016-02-12 2017-08-17 Axonics Modulation Technologies, Inc. External pulse generator device and associated methods for trial nerve stimulation
US11071869B2 (en) 2016-02-24 2021-07-27 Cochlear Limited Implantable device having removable portion
JP6603423B2 (en) 2016-05-24 2019-11-06 シナジア メディカル Centering kit and corresponding method for aligning an external element relative to an implantable medical device
EP4084271A1 (en) 2016-09-21 2022-11-02 Tc1 Llc Systems and methods for locating implanted wireless power transmission devices
US10355532B2 (en) 2016-11-02 2019-07-16 Apple Inc. Inductive power transfer
US11197990B2 (en) 2017-01-18 2021-12-14 Tc1 Llc Systems and methods for transcutaneous power transfer using microneedles
US10759287B2 (en) 2017-10-13 2020-09-01 Ossiaco Inc. Electric vehicle battery charger
EP3735733B1 (en) 2018-01-04 2024-01-17 Tc1 Llc Systems and methods for elastic wireless power transmission devices
CN111741789A (en) 2018-02-22 2020-10-02 艾克索尼克斯调制技术股份有限公司 Neural stimulation leads for testing neural stimulation and methods of use
US10784705B2 (en) 2018-04-27 2020-09-22 Medtronic, Inc. Recharging power sources of implantable medical devices
WO2020185902A1 (en) 2019-03-11 2020-09-17 Axonics Modulation Technologies, Inc. Charging device with off-center coil
US11547862B2 (en) * 2019-04-15 2023-01-10 Advanced Neuromodulation Systems, Inc. Wireless power transfer circuit for a rechargeable implantable pulse generator
WO2020242900A1 (en) 2019-05-24 2020-12-03 Axonics Modulation Technologies, Inc. Trainer device for a neurostimulator programmer and associated methods of use with a neurostimulation system
US11439829B2 (en) 2019-05-24 2022-09-13 Axonics, Inc. Clinician programmer methods and systems for maintaining target operating temperatures
CN110665117A (en) * 2019-09-02 2020-01-10 苏州科量波尔电子科技有限公司 Implantable rehabilitation device and working method thereof
WO2021223970A1 (en) * 2020-05-06 2021-11-11 Biotronik Se & Co. Kg Local supply voltage regulation of a rechargeable medical implant via resonance tuning
US11724115B2 (en) 2020-12-30 2023-08-15 Advanced Neuromodulation Systems Inc. System and method for reducing heat of an implantable medical device during wireless charging
US20220320890A1 (en) * 2021-03-31 2022-10-06 Advanced Neuromodulation Systems, Inc. Wireless power transfer and heat mitigation circuit for a rechargeable implantable pulse generator
WO2023130132A1 (en) * 2022-01-02 2023-07-06 Arkady Glukhovsky Device and method for evaluating coupling with an implantable device

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3195540A (en) * 1963-03-29 1965-07-20 Louis C Waller Power supply for body implanted instruments
US3454012A (en) * 1966-11-17 1969-07-08 Esb Inc Rechargeable heart stimulator
US3667477A (en) * 1966-11-25 1972-06-06 Canadian Patents Dev Implantable vesical stimulator
US3867950A (en) * 1971-06-18 1975-02-25 Univ Johns Hopkins Fixed rate rechargeable cardiac pacemaker
US3775661A (en) * 1972-05-23 1973-11-27 Frezzolini Electronic Inc Rechargeable battery power source with gas-pressure switch
US3888260A (en) * 1972-06-28 1975-06-10 Univ Johns Hopkins Rechargeable demand inhibited cardiac pacer and tissue stimulator
US3824129A (en) * 1973-03-14 1974-07-16 Mallory & Co Inc P R Heart pacer rechargeable cell and protective control system
US3942535A (en) * 1973-09-27 1976-03-09 G. D. Searle & Co. Rechargeable tissue stimulating system
US4572191B1 (en) * 1974-04-25 2000-10-24 Mirowski Miecyslaw Command atrial cardioverter
US3865101A (en) * 1974-05-01 1975-02-11 Datascope Corp Portable and separable heart monitor and heart defibrillator apparatus
FR2283590A1 (en) * 1974-08-30 1976-03-26 Commissariat Energie Atomique NERVOUS STIMULATION PROCESS AND APPLICATION STIMULATOR OF THE PROCESS
US4014346A (en) * 1975-06-26 1977-03-29 Research Corporation Hermetically sealed cardiac pacer system and recharging system therefor
JPS52151835A (en) * 1976-04-30 1977-12-16 Univ Johns Hopkins Enclosed battery
US4082097A (en) * 1976-05-20 1978-04-04 Pacesetter Systems Inc. Multimode recharging system for living tissue stimulators
US4096856A (en) * 1976-09-03 1978-06-27 Physio-Control Corporation Portable electronic physiological instrument having separable first and second components, and improved mechanical connector therefor
US4134408A (en) * 1976-11-12 1979-01-16 Research Corporation Cardiac pacer energy conservation system
US4172459A (en) * 1977-10-17 1979-10-30 Medtronic, Inc. Cardiac monitoring apparatus and monitor
US4275739A (en) * 1979-01-26 1981-06-30 The Johns Hopkins University Charge control switch responsive to cell casing deflection
US4323075A (en) * 1979-07-02 1982-04-06 Mieczyslaw Mirowski Battery failure compensation for a power supply used in an implantable defibrillator
JPS56106663A (en) * 1980-01-31 1981-08-25 Tokyo Shibaura Electric Co Transmitting medium for energy to organism buried device
US4409647A (en) * 1981-03-12 1983-10-11 Harry Terkanian Power converter using a resonant circuit
US4548209A (en) * 1984-02-06 1985-10-22 Medtronic, Inc. Energy converter for implantable cardioverter
EP0471421B1 (en) * 1984-12-28 1996-05-22 Kabushiki Kaisha Toshiba Stabilizing power source apparatus
US4635639A (en) * 1985-01-08 1987-01-13 Physio-Control Corporation Modular physiological instrument
US4665896A (en) * 1985-07-22 1987-05-19 Novacor Medical Corporation Power supply for body implant and method of use
US4827936A (en) * 1986-05-14 1989-05-09 Ventritex Apparatus for stimulating the heart with protected pacer
US4661107A (en) * 1986-07-21 1987-04-28 Fink Irving E Heart valve
US4787389A (en) * 1987-07-16 1988-11-29 Tnc Medical Devices Pte. Ltd. Using an implantable antitachycardia defibrillator circuit
US4903699A (en) * 1988-06-07 1990-02-27 Intermedics, Inc. Implantable cardiac stimulator with automatic gain control
US5350413B1 (en) * 1990-06-21 1999-09-07 Heart Inst Research Corp Transcutaneous energy transfer device
DE4104359A1 (en) * 1991-02-13 1992-08-20 Implex Gmbh CHARGING SYSTEM FOR IMPLANTABLE HOERHILFEN AND TINNITUS MASKERS
US5184059A (en) * 1991-09-16 1993-02-02 Motorola, Inc. Expanded battery capacity identification scheme and apparatus
US5314453A (en) * 1991-12-06 1994-05-24 Spinal Cord Society Position sensitive power transfer antenna
US5285779A (en) * 1992-03-27 1994-02-15 Hewlett-Packard Company Method and apparatus for a cardiac defibrillator high voltage charging circuit
US5411537A (en) * 1993-10-29 1995-05-02 Intermedics, Inc. Rechargeable biomedical battery powered devices with recharging and control system therefor
US5690693A (en) * 1995-06-07 1997-11-25 Sulzer Intermedics Inc. Transcutaneous energy transmission circuit for implantable medical device

Also Published As

Publication number Publication date
EP0934101A1 (en) 1999-08-11
WO1998011942A1 (en) 1998-03-26
US5702431A (en) 1997-12-30

Similar Documents

Publication Publication Date Title
CA2265984A1 (en) Enhanced transcutaneous recharging system for battery powered implantable medical device
US5690693A (en) Transcutaneous energy transmission circuit for implantable medical device
US7177691B2 (en) Implantable pulse generators using rechargeable zero-volt technology lithium-ion batteries
US9446250B2 (en) Implantable medical device with multi-function single coil
US7295878B1 (en) Implantable devices using rechargeable zero-volt technology lithium-ion batteries
CA2826117C (en) Smart charger alignment indicator
US5279292A (en) Charging system for implantable hearing aids and tinnitus maskers
CN105126248B (en) For treating the nerve stimulation apparatus of chronic inflammation and system
US20040098068A1 (en) Chair pad charging and communication system for a battery-powered microstimulator
WO1998010836A1 (en) Data communication system for control of transcutaneous energy transmission to an implantable medical device
US20190070421A1 (en) Supercapacitor-Powered Charger and Implantable Medical Device

Legal Events

Date Code Title Description
FZDE Dead